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Definitions used in the thesis 
The definitions of UI were updated in 2010 in the Report from the 
standardization sub-committee of the International Continence Society and 
International Urogynecology Association [Haylen 2010].  
- Urinary incontinence: the complaint of any involuntary leakage of urine.  
- Stress urinary incontinence: the complaint of any involuntary leakage of 
urine on effort or exertion or sneezing or coughing.  
- Urgency urinary incontinence: the complaint of any involuntary leakage 
of urine accompanied by or immediately proceeded by urgency.  
- Mixed urinary incontinence: the complaint of any involuntary leakage of 
urine associated with urgency and also with effort or exertion or 
sneezing or coughing.  
Incident UI is defined as cumulative incidence of any UI during a certain time 
periode. Incident stress, urge or mixed UI is defined as new onset of either 
stress, urge or mixed UI during a certain time period.   
The definitions of BMI are based on WHO’s definitions of underweight, normal 
weight and overweight.  
- BMI   weight (kg) / (height in meters)2
- Underweight BMI < 18,5 kg/m2
- Normal weight BMI 18,5 – 24,9 kg/m2
- Overweight  BMI  25 kg/m2
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The definitions of obstetric variables in MBRN are based on Clinical guidelines 
in obstetric, 1999, written by The Norwegian society of obstetrics and 
gynecology [Dalaker K 1999]. 
- Elective CS: A planned CS usually performed 1-2 weeks due to term. 
- Non – elective/acute CS: Emergency CS due to complications in mother 
or child.  
- Vaginal delivery: Represents SVD, forceps delivery or vacuum delivery. 
- Apgar score: Number arrived at by scoring the heart rate, respiratory 
effort, muscle tone, skin colour, and response to a catheter in the nostril. 
Each of these objective signs can receive 0, 1, or 2 points. 
- Fetal presentation: Normal occipital, breech, transverse, abnormal fetal 
head presentation or other. 
- Perineal tear grade 3: Fourchette, perineal skin, vaginal mucosa, 
muscles, and anal sphincter are torn. 
- Perineal tear grade 4: Fourchette, perineal skin, vaginal mucosa, 
muscles, anal sphincter and rectal mucosa are torn.
General definitions on parity: 
- Nulliparous: A woman who is pregnant with her first child. 
- Primiparous: A woman who has delivered her first child. 
- Parous: A woman who has delivered a child. 
- Multiparous: A woman who has delivered more than one child.  
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Abstract 
Urinary incontinence (UI) is a common condition among women. The 
prevalence of UI is high both during and after pregnancy, and childbearing is 
an established risk factor for UI among young and middle-aged women. 
However, incidence and prevalence estimates of UI in association with 
pregnancy vary widely. Only a few population based studies have investigated 
prevalence of UI in pregnancy by type and severity. Data are inconsistent 
regarding several risk factors for UI in pregnancy.
UI starting before or in pregnancy is likely to predict UI postpartum. The role of 
incident UI in pregnancy has received little attention as a predictor for UI 
postpartum and later in life. Few authors have studied the effect of delivery 
mode on UI among primiparous women. Weight gain in pregnancy is thought 
to contribute to the increased prevalence of UI during and after pregnancy, but 
scientific support is lacking. The effect of weight loss on UI postpartum is 
unclear.  
The data collection for the current study was conducted as part of the 
Norwegian Mother and Child Cohort Study (MoBa) at the Norwegian Institute 
of Public Health. From 1999 to 2009, investigators in MoBa invited all pregnant 
women in Norway to participate in the study 2 weeks before the routine 
pregnancy ultrasound examination, aiming at a study population of 100,000 
pregnant women. Our sub studies are based on available data at the time from 
this study population. The MoBa study was comprehensive, obtaining data by 
questionnaires of 14–18 pages length at seven time points from week 15 in 
pregnancy to 7 years after birth. We used questionnaire data from 
Questionnaire 1 received in week 15 of pregnancy, Questionnaire 3 received 
in week 30 and Questionnaire 4 received six months postpartum.  
In Paper I we used data obtained from 43,279 women who had answered 
Questionnaire 3. The study showed that the prevalence of UI increased from 
26% before pregnancy to 58% in week 30. The corresponding figures for 
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nulliparous women were 15% and 48%, and for parous women 35% and 67%. 
The cumulative incidence was 46%. Stress UI was the most common type of 
UI in week 30 of pregnancy. Before and in pregnancy the majority of pregnant 
women leaked less than once per week and droplets only. Parity was a strong 
and significant risk factor for UI in adjusted analyses both before pregnancy 
(OR 3.3, 95% CI 3.1–3.5) and in pregnancy (OR 2.1, 95% CI 2.0 –2.2) among 
parous women compared to nulliparous women. Increasing age and BMI were 
weaker, but still statistically significant, risk factors. 
In Paper II we selected nulliparous women who were continent before 
pregnancy and who had answered Questionnaire 1, 3 and 4 from the above 
dataset; at total of 12,679 women. Results were stratified for mode of delivery 
and continence status in pregnancy. UI was reported by 31% of the women 6 
months after delivery. Compared with women who were continent in 
pregnancy, UI was more prevalent 6 months after delivery among women who 
were incontinent in pregnancy (adjusted RR 2.3, 95% CI 2.2–2.4). Adjusted 
RR for UI after SVD compared with elective CS was 3.2 (95% CI 2.2–4.7) 
among women who were continent and 2.9 (95% CI 2.3–3.4) among women 
who were incontinent in pregnancy.  
In Paper III we used the same dataset as in Paper II. We found that weight 
gain > 50th percentile during weeks 0–15 of pregnancy was weakly associated 
with higher incidence of UI at week 30 compared with weight gain  50th 
percentile. Weight gain > 50th percentile in pregnancy was not associated with 
increased prevalence of UI 6 months postpartum. Weight gain > 50th 
percentile from the start of pregnancy to 6 months postpartum was more 
strongly associated with having UI 6 months postpartum than was high weight 
gain in any single sub period. Each kilogram of weight gain in this time period 
increased the RR for UI by 2.3% (RR 1.02, 95% CI 1.02–1.03). From delivery 
to 6 months postpartum, there was a clear association between weight loss 
and lower prevalence of UI among women who were continent and as well as 
those among those who were incontinent in pregnancy. For each kilogram of 
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weight loss among all women who were incontinent in pregnancy, the relative 
risk for UI decreased by 2.1% (RR 0.98, 95% CI 0.97-0.99). 
Main findings in the thesis: 
- The prevalence of UI was high before pregnancy. Prevalence increased 
substantially in pregnancy and was reduced postpartum. Prevalence of 
UI postpartum was, however, higher than before pregnancy.  
- UI in pregnancy was associated with UI postpartum. Vaginal delivery 
was a strong independent risk factor for UI postpartum.  
- The association between UI postpartum and mode of delivery was not 
significantly influenced by incontinence status in pregnancy. Prediction 
of a group with high risk of incontinence postpartum by mode of delivery 
cannot be based on continence status in pregnancy. 
- Weight gain in the beginning of pregnancy was weakly associated with 
UI in pregnancy. The association is not likely to be of clinical importance 
as the weight gain in beginning of pregnancy was not associated with UI 
postpartum. Weight loss postpartum seemed to have an impact in 
avoiding UI and regaining continence 6 months postpartum. 
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Sammendrag (abstract in Norwegian)  
Urininkontinens (UI) er en vanlig tilstand blant kvinner. Prevalensen av UI er 
høy både under og etter svangerskapet. Graviditet er en etablert risikofaktor 
for UI blant yngre og middelaldrende kvinner. Imidlertid varierer insidens og 
prevalensestimatene for UI i forbindelse med svangerskap betydelig. Få 
populasjonsbaserte studier har undersøkt type og alvorlighet av UI under 
svangerskapet. Det er også sprikende resultater angående risikofaktorer for 
UI. 
UI som oppstår før eller under svangerskapet kan sannsynligvis predikere UI 
etter fødsel. UI. Nyoppstått UI under svangerskapet har foreløpig fått lite 
oppmerksomhet som prediktor UI etter fødsel. Få forskere har undersøkt 
effekten av forløsningsmetode på UI hos førstegangsfødende kvinner. Man 
har lenge trodd at vektøkning under svangerskapet i betydelig grad har bidratt 
til den økte UI under svangerskapet, men vitenskapelig dokumentasjon 
mangler. Effekten av vekttap etter fødsel på UI etter fødsel er uklar.  
Datainnsamlingen for denne studien ble gjennomført av Den Norske Mor og 
Barn Undersøkelsen (MoBa) ved Folkehelseinstituttet. Fra 1999 til 2009 ble 
alle gravide norske kvinner invitert til å delta i studiet 2 uker før rutine 
ultralydsundersøkelse. Målet var å rekruttere 100,000 gravide kvinner. Våre 
substudier baserte seg på daværende tilgjengelige data fra MoBa studien. 
MoBa studien var omfattende med innsamling av 14 – 18 siders spørreskjema 
ved syv anledninger fra uke 15 i svangerskapet til 7 år etter fødsel. Vi benyttet 
data fra spørreskjema som ble utsendt i uke 15 (spørreskjema 1) og 30 
(spørreskjema 3) av svangerskapet og 6 måneder etter fødsel (spørreskjema 
4).  
I Artikkel I benyttet vi data fra 43,279 som hadde besvart spørreskjema 1 og 3. 
Studien viste at hyppigheten av UI økte fra 26 % før svangerskapet til 58 % i 
uke 30. Tallene for førstegangsfødende var 15 % og 48 %, for 
flergangsfødende 35 % og 67 %. Nyoppstått UI forekom hos 46 %. Stress UI 
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var den vanligste formen for UI i uke 30. Under og etter svangerskapet hadde 
majoriteten av gravide kvinner lekkasje sjeldnere enn 1/uke og kun noen 
dråper. Tidligere fødsler var en sterk og signifikant risikofaktor for UI i justerte 
analyser både før svangerskap (OR 3.3 95 % CI 3.1–3.5) og under 
svangerskap (OR 2.1 95 % CI 2.0–2.2) blant flergangsgravide kvinner 
sammenlignet med førstegangsgravide kvinner. Alder og kroppsmasseindex 
var svakere, men fortsatt statistisk signifikante risikofaktorer.  
I Artikkel II selekterte vi førstegangsfødende kvinner som var kontinente før 
svangerskapet og som hadde besvart spørreskjema 1, 3 og 4 fra MoBa; totalt 
12,679 kvinner. Resultatene ble stratifisert for forløsningsmetode og 
kontinensstatus under svangerskapet. UI ble rapportert av 31 % av kvinnene 6 
måneder etter fødsel. UI mer prevalent 6 måneder etter fødsel blant kvinner 
som var inkontinent under svangerskapet (OR 2.3 95 % CI 2.2–2.4) 
sammenlignet med kvinner som var kontinente under svangerskapet. Justert 
RR for UI etter spontan vaginal forløsning sammenlignet med keisersnitt var 
3.2 (95 % CI 2.2–4.7) blant kvinner som var kontinente og 2.9 (95 % CI 2.3–
3.4) blant kvinner som var inkontinente under svangerskapet.  
I Artikkel III benyttet vi samme datasett som i Artikkel II. Vi fant at vektøkning > 
50 prosentilen i uke 0 – 15 i svangerskapet var svakt assosiert med høyere 
innsidens av UI i uke 30 av svangerskapet sammenlignet med vektøkning  50 
prosentilen. Vektøkning > 50 prosentilen under svangerskapet var ikke 
assosiert med økt hyppighet av UI 6 måneder etter fødsel. Vektoppgang > 50 
prosentilen fra begynnelsen av svangerskapet til 6 måneder etter fødsel var 
sterkere assosiert med UI enn vektoppgang i noen annen tidsperiode. For 
hvert kg vektøkning økte RR for UI med 2.3 % (RR 1.02; 95 % CI 1.02–1.03). 
Fra fødsel til 6 måneder etter fødsel var det en klar assosiasjon mellom 
vekttap og lavere prevalens av UI både blant kvinner som var kontinent og 
blant kvinner som var inkontinent under svangerskapet. For hvert kg 
vektreduksjon blant kvinner som var inkontinent under svangerskapet sank RR 
for UI 2.1 % (RR 0.98 95 % CI 0.97–0.99). 
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Hovedfunn i denne avhandlingen: 
- Prevalensen av UI var høy før svangerskapet. Prevalensen økte 
betydelig under svangerskapet og ble redusert etter fødsel. Prevalensen 
etter fødsel var imidlertid høyere enn før svangerskapet.  
- UI under svangerskapet var assosiert med UI etter fødsel. Vaginal 
forløsning var en sterk uavhengig risikofaktor for UI etter fødsel. 
- Assosiasjonen mellom UI etter fødsel og forløsningsmetode ble ikke 
signifikant påvirket av kontinentsstatus under svangerskapet. Prediksjon 
av en gruppe kvinner med høy risiko for UI etter fødsel på bakgrunn av 
forløsningsmetode kunne ikke baseres på kontinentsstatus under 
svangerskapet.  
- Vektøkning i begynnelsen av svangerskapet var svakt assosiert med UI 
under svangerskapet, men assosiasjonen er trolig ikke klinisk 
betydningsfull da vektøkning under svangerskapet totalt sett kke var 
assosiert med UI etter fødsel. Vekttap etter fødsel så ut til å være viktig 
for å unngå UI og gjenvinne kontinens 6 måneder etter fødsel.  
_____________________________________________________________________ 
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1. Introduction 
This introduction will present background information about incidence, 
prevalence and risk factors for UI in pregnancy and postpartum. In addition, 
the introduction will discuss aspects on the association between UI and weight 
that are beyond weight change in pregnancy.  
I will not refer to Paper I, Paper II or Paper III in the introduction, as these 
papers will be thoroughly discussed in the Discussion section. 
1.1 Incidence and prevalence of UI in pregnancy 
Incidence 
UI is common among nulliparous women. A Norwegian study found 
prevalence of UI among nulliparous women aged 20 – 34 and 35 – 44 to be 8 
% and 15 %, respectively [Rortveit 2001]. Other studies have found that 11 % 
[Brown 2010, MacLennan 2000] of nulliparous women had UI before 
pregnancy. Prevalence of UI increases considerably in pregnancy due to 
increased incidence of stress and mixed UI [Solans-Domenech 2010]. 
No systematic review has presented pooled incidence of UI in pregnancy. 
Epidemiologic data are somewhat scarce and differ substantially for 
cumulative incidence of UI in pregnancy; from 8 – 57 % in different studies 
(Table 1).  
Incidence of UI is low in 1. trimester, rising rapidly in 2. trimester and continues 
to rise, though more slowly, in 3. trimester [Marshall 1998, Morkved 1999, 
Solans-Domenech 2010]. A large Spanish cohort study from 2010 consisting 
of 1,128 nulliparous women who were continent before pregnancy had 
questionnaire data from each trimester. Sandvik’s severity index and short 
version of the International Consultation on Incontinence questionnaire were 
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used. The article reported a cumulative incidence of UI in pregnancy of 39 % 
[Solans-Domenech 2010]. An Australian cohort study from 2009 consisting of 
1,507 primiparous women had interview data from early and late pregnancy. 
Sandvik’s severity index and an incontinence screening questionnaire for 
female primary care were used. The authors found an incidence of any UI of 
45 % in pregnancy [Brown 2010] (Table 1). These cohort studies have several 
similarities with our study. 
There are a few Scandinavian studies on incident UI in pregnancy. Authors of 
a Norwegian cross sectional study published data on incidence of UI in 
pregnancy based on interview and objective testing 8 weeks postpartum. They 
found an incidence of 38 % of UI in pregnancy [Morkved 1999]. Authors of a 
Swedish cohort study followed pregnant women from week 12 to 36. By 
repeated measurements they found an incidence of stress UI of 16 % in week 
36 [Kristiansson 2001]. A Danish cross sectional retrospective study found an 
incidence of UI of 17 % in pregnancy [Hvidman 2002]. By interview and 
examination a 30 years old large Swedish cohort study on incident stress UI in 
pregnancy reported that 16 % of women experience stress UI for the first time 
in pregnancy [Iosif 1981] (Table 1).  
Several studies on incident UI in pregnancy are cross sectional. Some 
obtained data on any UI while others had data on stress UI only, some use 
questionnaire data while others use interview and objective testing. This might 
explain the diverging estimates (Table 1). The MoBa study can help us 
estimate incidence of UI in pregnancy. 
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Prevalence  
I have not been able to find any systematic review presenting pooled 
prevalence of UI in pregnancy. The ICI report describes period prevalence of 
any UI in pregnancy of 32 – 64% among all women [Milsom 2009]. Prevalence 
estimates for UI in pregnancy among nulliparous women vary from 4 – 70 %, 
while estimates for parous women vary from 14 – 85 % (Table 2).  
Dolan et al investigated prevalence of any UI during week 32 to term in a 
cohort of 492 nulliparous women in England [Dolan 2004]. The Kings Health 
Questionnaire was used to assess any UI. Prevalence of UI was 36 % in 
pregnancy. However, prevalence of UI before pregnancy was only 2.6 %, 
which might explain a somewhat low UI prevalence during pregnancy. An 
Australian cohort study consisting of 1,507 nulliparous women found 
prevalence of any UI of 56 % in week 31 of pregnancy [Brown 2010] (Table 2). 
Of several Scandinavian studies presenting prevalence of UI in pregnancy, 
only 3 were cohorts (Table 2). Iosif et al interviewed and examined 1,411 
pregnant women in a Swedish cohort. They found that 22 % of all pregnant 
women experienced stress UI in pregnancy [Iosif 1981]. Another Swedish 
cohort study of 200 nulliparous women found by questionnaire a prevalence of 
stress UI in pregnancy of 26 % among all women [Kristiansson 2001]. In a 
Danish cohort 305 primiparous women were interview in pregnancy regarding 
UI. 32 % of the women experienced stress UI in pregnancy [Viktrup 1992]. A 
Norwegian retrospective cross sectional study found prevalence of UI in 
pregnancy to be 37 – 70 %, depending of parity [Morkved 1999]. 
There are large differences in estimates of UI in pregnancy. Few Scandinavian 
pregnancy cohorts on UI have been performed, and authors of these cohorts 
reported data on stress UI only. A new large prospective cohort on pregnant 
women, like the MoBa, will get new valid data on any UI in pregnancy. 
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1.2 Incidence and prevalence of UI postpartum 
Incidence 
Prevalence of UI postpartum is a so called “mixed bag” of incident UI before 
pregnancy, incident UI in pregnancy and incident UI postpartum [Iosif 1981, 
Nygaard 2006]. Risk factors for incident UI at the different time points vary. 
Among several risk factors, pregnancy itself is a risk factor for UI in pregnancy. 
Mode of delivery is a risk factor for UI postpartum [Glazener 2006].  
No systematic review on incident UI postpartum has been identified. In a 
review on the association between CS on UI postpartum Nygaard reported the 
range of incident UI postpartum to be 7 – 15 % among all women [Nygaard 
2006]. The reported incidence of UI among primiparous and parous women 
postpartum varies between 0 – 26 % and 4 – 21 %, respectively (Table 3).  
A prospective cohort had data on incident UI 6 months postpartum; among 
595 primiparous Canadian women 6 months postpartum, Farrell et al found by 
validated questionnaire an incidence of any UI of 26 % [Farrell 2001] (Table 3). 
The use of a research nurse to clarify and complete the questionnaire with 
each participant might explain the high incidence. 
Two Scandinavian cohort studies have reported incidence of UI postpartum; in 
the Swedish cohort of 1,411 primiparous women, 19 % reported incident 
stress UI 6 months post partum [Iosif 1981]. In the Danish cohort of 305 
primiparous women Viktrup et al found an incidence of stress UI of 7 % 3 
months after vaginal delivery [Viktrup 1992] (Table 3).  
Figures of incident UI post partum varies a lot. Scandinavian cohorts on UI 
postpartum are 20 – 30 years old. Definitions and statistical methods have 
changed and developed. There is need for a new large cohort like the MoBa 
study on UI postpartum.  
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Prevalence 
Several reviews present prevalence of UI postpartum. In a review on UI and its 
precipitating factors postpartum Herbruck reported prevalences of stress UI of 
22 – 33 % postpartum among all women [Herbruck 2008]. The ICI 
epidemiology report presented prevalence of 15–30 % among all women the 
1. year postpartum [Milsom 2009]. In a review Nygaard reported the 
prevalence of UI postpartum to be 9 – 31 % among all women [Nygaard 2006]. 
Authors of a systematic review reported a pooled prevalence of UI of 29 % and 
33 % 3 months postpartum among primiparous and parous women, 
respectively [Thom 2010] (Table 4). The range of prevalence among 
primiparous women (6–67 %) and parous women (3–45 %) are, however, 
wider than the impression given in rewievs (Table 4).  
Several studies have presented data on the long term prognoses of UI 
postpartum. Farrell found that prevalence of UI did not change from 6 weeks 
postpartum to 6 months postpartum [Farrell 2001]. A systematic review found 
only small changes in prevalence of UI over the first year postpartum [Thom 
2010]. A 12 year prospective study indicates that onset of UI in pregnancy or 
postpartum increased the risk for UI 12 years later [Viktrup 2006]. As 
prevalence figures of UI postpartum appear to be stable, time point of data 
collection postpartum may be of less importance.  
A large cohort study on 2,390 Swedish women recruited in pregnancy 
assessed stress UI at 2 and 12 months postpartum by questionnaire [Schytt 
2004]. UI was defined as any UI last week. Data was linked to the Swedish 
birth registry. The authors found that 18 % of primiparous women and 24 % of 
multiparous women had stress UI 12 months postpartum. In the Danish cohort 
from 1992 Viktrup et al found prevalence of stress UI 3 months postpartum to 
be 7 % among 305 primiparous women [Viktrup 1992]. There are large 
differences in estimates of UI postpartum (Table 4). A large national cohort on 
pregnant women like MoBa is desirable, as it would be the first of its kind. 
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1.3 Why do estimates differ? 
A wide range of prevalence estimates of UI in pregnancy and postpartum have 
been presented. There are several methodological reasons for these diverging 
incidence and prevalence estimates.  
UI definition 
UI can be defined as a:  
- symptoms (a morbid phenomenon or departure from the normal in structure, 
function, or sensation, experienced by the woman and indicative of disease or 
a health problem) [Abrams 1988, Abrams 2002, Haylen 2010] 
- signs (observed by the physician to verify symptoms and quantify them) 
[Abrams 1988, Abrams 2002, Haylen 2010] 
- urodynamic findings (observations made during urodynamic studies) [Abrams 
2002] 
- conditions (the presence of urodynamic observations associated with 
characteristic symptoms or signs and/or non-urodynamic evidence of relevant 
pathological processes) [Abrams 2002] 
The ICS definitions and terminologies of UI according to the above 
descriptions have been revised several times [Abrams 1988, Abrams 2002, 
Haylen 2010]. The current definition of UI symptoms is “Complaint of 
involuntary loss of urine” [Haylen 2010]. In the 2002 defintion, UI symptoms 
were not enough to set the UI diagnose; UI signs were needed. Today the 
majority of studies on UI define UI according to UI symptoms. Studies on UI 
have used the definitions at the time. As definitions change, prevalence 
estimates will also change.  
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Information gathering 
Information on UI in pregnancy and postpartum is often gathered through 
questionnaires, but objective testing [Morkved 1999], personal structured 
interviews [Chiarelli 1997, Morkved 1999] or semi structured interviews 
[Spellacy 2001] or phone interviews [Baydock 2009] by doctors or assistants, 
or reviews of existing medical records [Spellacy 2001] are also used. 
Information collected by interview makes it possible to clarify and gather more 
and better information regarding UI. This type of data collection is likely to lead 
to higher prevalence figures of UI than for instance questionnaire [Chiarelli 
1997]. Medical records often lack important information, leading to low 
prevalence estimates. Studies have found low agreement between self 
reported UI and clinical assessment [Diokno 1988, Milsom 1993]. Objective 
testing according to the “UI sign” definition will lead to lower prevalence 
estimates than questionnairebased studies using the “UI symptom” definition. 
Type of study 
A large proportion of studies on UI in pregnancy or postpartum are cross 
sectional (Table 1 – 4) or retrospective. If a woman has UI when answering a 
retrospective study, this may affect her reporting of UI by improving her 
memory about earlier UI leading to a recall bias. Cross sectional studies have 
less valid incidence figures than prospective cohorts.  
Timing of data collection 
Timing of data collection can affect prevalence estimates of UI in pregnancy. 
Some studies question women about UI during each trimester, but most 
studies question women at one certain time point in pregnancy [Brown 2010, 
Lewicky-Gaupp 2008] or just after birth [Sottner 2006]. Some studies do not 
report what time in pregnancy the women reported UI [Sharma 2009]. As 
prevalence of UI increases in pregnancy, the time of information gathering will 
affect the prevalence estimates. When it comes to data collection postpartum 
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some studies report on UI at 6 - 9 weeks postpartum [D'Alfonso 2006, 
Lewicky-Gaupp 2008, Meyer 1998], 3 months [Eason 2004, Hannah 2002], 4 
months [Baydock 2009], 6 months [Thomason 2007], 12 months [Serati 2008] 
or > 12 months [Foldspang 2004, Fritel 2004] postpartum. The time of 
information gathering postpartum might affect incidence and prevalence 
estimates of UI. However, a recent review indicates that prevalence of UI is 
stable first year postpartum [Thom 2010], and time of data collection 
postpartum may therefore be of less importance.   
Threshold 
Permanence, frequency and volume are used by authors as threshold to 
define women with UI in association with pregnancy. Permanence or duration 
can be defined as one or more episodes of UI in the previous month [Brown 
2010, Wilson 1996]. Some authors use longer periods, like trimesters [Schytt 
2004] or the 6 months postpartum period [Schytt 2004]. Some authors 
investigate severe UI defined by weekly or daily leakage [Al-Mehaisen 2009] 
while others do not report any cut-off [van Brummen 2006b]. Some studies 
have a cut-off for minimum frequency, amount or severity of UI for women to 
be included in the study as incontinent. A high cut-off decreases the number of 
women who fulfil the UI criteria in a study. Differing thresholds may explain 
differing incidence and prevalence estimates of UI.  
Type of UI 
Stress UI is more common in pregnancy and postpartum than urge UI and 
mixed UI. Also, the incidence of pure urge UI in pregnancy or postpartum is 
low compared to incidence of stress UI and mixed UI. The prevalence of pure 
stress UI is reported to be 2 – 8 times higher than the prevalence of pure urge 
UI in pregnancy [Brown 2010, Goldberg 2005, Raza-Khan 2006]. Prevalence 
of mixed UI is reported to be 0.3 – 1.5 times of the prevalence of pure stress 
UI in pregnancy [Brown 2010, Goldberg 2005, Raza-Khan 2006]. The 
stress/urge ratio is reduced postpartum as prevalence of stress UI decline. 
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Several studies focus solely on stress UI [Mason 1999, Torrisi 2007, Viktrup 
1992]. Prevalence figures in these studies are likely to be lower than in studies 
that include both urge UI and mixed UI in their analyses. 
Charecteristics of study population 
The study population influences prevalence of UI. Some studies on UI in 
association with pregnancy use study populations from tertiary care hospitals 
[Baydock 2009], leading to recruitment of highly selected participants. BMI 
distribution, age distribution, parity distribution, proportion of European or 
Hispanic population, proportion of women having vaginal delivery all influence 
prevalence figures of UI. Some studies include only women having SVD 
[Altman 2006, Arrue 2010, Baydock 2009], which will give a higher prevalence 
estimate of UI than if the study also had included CS. Many studies on UI in 
association with pregnancy either adjust or report stratified analyses for age 
[Solans-Domenech 2010], BMI [Eason 2004], race [Connolly 2007] and mode 
of delivery [Eason 2004]. Effect estimates are therby controlled for baseline 
imbalances in these important patient characteristics. However, dissimilar use 
of statistical stratification and adjustment makes it difficult to compare findings. 
Pooled prevalences figures can be misleading and readers should be careful 
in generalising the findings to a population outside the study population.  
Bias 
Many studies on UI in pregnancy try to gather information from all pregnant 
women in the community [Boyles 2009, Thompson 2002]. In large studies with 
an open invitation and no follow – up of non – responders to the invitation it 
can be difficult to achieve high response rates. These studies are prone to a 
biased response rates/selection bias which may invalidate the prevalence 
estimates. Primiparous women are more likely to participate and tell their 
pregnancy stories in studies compared to parous women [Magnus 2006]. 
Known differences between responders and non-responders may be 
compensated during analyses. The major problem is unknown response bias, 
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such as the possibility of different response rates between continent and 
incontinent women [Cartwright 1983]. Due to embarrassment and feeling 
uncomfortable about reporting UI, incontinent women may deny or not answer 
questions about UI. Converely, incontinent women may find the subject 
particularly relevant, and therefore respond to a greater extent than continent 
women. At present, we do not know how these factors may affect the 
response rates. To minimise selection bias one should always aim at the 
highest possible response rates.  
All the above methodological factors can influence UI estimates in a study. 
Unfortunately we do not know all factors that influence UI estimates. Some 
variation in prevalence estimates between studies will always remain. 
1.4  What is a risk factor? 
A risk factor is a variable associated with an increased risk of the outcome. 
Risk factors imply association and not necessarily causality. 
Studies with large study populations are likely to find statistically significant 
associations. It does not, however, imply that the association is clinically 
significant; which means that the risk is large enough to be of practical 
importance to patients and healthcare providers. Assessing clinical 
significance takes into account factors such as the size of a treatment effect, 
the severity of the condition being treated, the side effects of the treatment, 
and the cost.  
There are several criteria for causation and risk factors. Hill’s Criteria of 
Causation from 1965 [Hill 1965] and Evan’s Postulates from 1976 are some. 
Several of these criteria are indirectly still being used when we talk about 
established risk factors. For a risk factor to be defined as “established”, “true” 
or “verified”, several items should be achieved:  
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- The effect size (OR, RR) tells us something about the strength, relevance 
and clinical importance of the risk factor. Statistical significance and 
confidence intervals tell us whether the risk factor is random or trustworthy.  
- A risk factor does not necessarily imply a cause and effect relationship. To be 
causal the risk factor must precede the outcome. This is why cross sectional 
studies provide weaker evidence than cohorts for causal relationships. 
-  A dose – response relationship strengthens the association. If the OR for a 
disease increases after increasing exposure for the risk factor, association is 
likely. If treatment, reduction of risk factor by purpose or by chance reduces 
the incidence of the outcome, this supports that there is a causal relationship.  
- Consistency in the literature regarding a risk factor increases the chance of 
validity. This implies that the risk factor is reproduced in several studies with 
different study populations at different times at different places.  
-  If the risk factor is biologically plausible and supported by biological 
evidence, it strengthens the possibility of causality. However, many 
epidemiological studies are prior to biological evidence, and lack of knowledge 
makes it thereby hard to explain how the risk factor acts on the outcome.  
There are proposed several risk factors for UI in general and for UI in 
pregnancy and post partum. Some of these suggested risk factors are listed in 
Table 5. Age, BMI, pregnancy, parity and mode of delivery are considered 
established risk factors, but there are inconsistent findings regarding most of 
the remaining listed risk factors.  
Some findings must be regarded as simple “associations” or “predictors”; for 
example education and income. In quantitative research, the term 
"association" is often used to emphasize that a relationship is not necessarily 
causal. It is difficult to find biological plausible evidence for these associations. 
Some findings are regarded as “risk factors” like age and SVD, as they meet  
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Table 5. Varialbles that might increase the risk of UI  
General risk factors for UI Risk factors for UI in association with pregnancy 
Increasing age Pregnancy per se 
Increasing BMI Increasing parity  
Low education Mode of delivery (SVD vs. CS) 
Low income Forceps, vacuum delivery vs SVD 
Smoking vs no smoking Increasing degree of laceration, perineal suturing 
Increasing alcohol consumption Episiotomy vs no episiotomy 
Race (white vs. black) Increasing length of 2. stage labour,  
increasing total duration of labour 
Hereditary factors Delivery position, fetal head presentation  
Increasing exercise  Increasing head circumference 
Increasing intake of fatty food Increasing birth weight 
Diabetes  Increasing weight gain in pregnancy  
Depression UI before pregnancy vs no UI before pregnancy 
Asthma, COPD UI in pregnancy vs no UI in pregnancy 
Constipation Pudendal block, epidural analgesia vs no anesthesia 
Nocturia Induction of labour vs no induction 
Hormone therapy Increasing length of breast feeding
Age at menopause Increasing striae 
Degree of pelvic organ prolapse Increasing age at first childbirth 
all the Hill’s criteria to be characterised as established causlal risk factors. 
Some findings can be said to be in the grey zone between a risk factor and an 
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associated factor. A condition today can hardly be characterised as a risk 
factor for the same condition tomorrow. If UI is a stable chronic condition, UI in 
pregnancy can only be a predictor, or associated with UI postpartum. 
However, if UI during pregnancy and UI postpartum are conditions at separate 
times due to separate risk factors, they might be regarded as partly 
independent. In this setting, UI is not a stable condition, and authors therefore 
often characterise UI in pregnancy as a risk factor for UI postpartum.  
Few risk factors for UI in pregnancy and postpartum are well documented and 
established. There is a need of studies designed to further investigate risk 
factors associated with UI in pregnancy and postpartum.  
1.5 CS to prevent UI 
Several studies and reports from high – income [Collins 2001, Kozak 2002] 
and low – income countries [Behague 2002, Sreevidya 2003] confirm 
increasing rates of CS. During the last 50 years Norway has had an increase 
in CS rate; from 1.8 % in 1967, 6.4 % in 1977, 12.8 % in 1997 to 16.7 % in 
2007 [MBRN 2010]. Norway has however a low CS rate compared to similar 
countries. Surveys on both women [Wax 2004] and obstetricians [Al-Mufti 
1997] suggest that a significant proportion would choose to have their own 
baby delivered by CS. The reasons for increasing CS rates are diverging.   
Risks involved by undergoing an elective CS should always be kept in mind 
before CS is performed as UI prophylaxis. Today prophylactic elective CS is 
promoted to prevent postpartum UI without robust evidence to support this 
practice [Dietz 2006, Handa 1996, Leijonhufvud 2011]. Some studies indicate 
that CS reduces risk of UI, but the clinical significance of these findings 
remains unclear.  
1.5.1 Effect of mode of delivery on UI in the short and long run? 
Some studies have investigated the effect of CS on UI. A systematic review 
[Press 2007] identified two cross sectional studies [MacLennan 2000, Rortveit 
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2003a] with data on primiparous women with results on the effect of CS 
compared to SVD on stress UI postpartum. The review presented pooled 
prevalences of stress UI after CS (9 %) and SVD (14 %), leading to an OR of 
0.59 (95% CI 0.40 – 0.87) [Press 2007]. There were no significant differences 
between urge UI and mixed UI after CS compared to SVD.  
In the EPINCONT study [Rortveit 2003a], a large cross sectional study from 
Norway including 15,307 women who had only delivered by CS or vaginal 
delivery, the prevalence of any UI was 16 % among women who had delivered 
by CS only, and 21 % in women following VD only. In women 50 – 64 years 
there was no significant risk difference between women delivering by CS or 
vaginal delivery. The protective effect of CS seems to be apparent until women 
are 50 years of age. These findings are supported by other studies, indicating 
that nulliparous and multiparous postmenopausal women have rather similar 
risk of UI [Buchsbaum 2002]. One study has performed urodynamic 
investigation among climacteric women [Guarisi 2002]. There was no 
difference in uroflowmetry parameters among women who had delivered by 
CS and vaginal delivery.  
The same review [Press 2007] presented pooled prevalences of UI postpartum 
based on data on primiparous women in cohort studies [Press 2007]. Five 
articles were identified [Fritel 2004, Klein 2005, Schytt 2004, Thompson 2002, 
Wilson 1996]. Pooled prevalence of stress UI after CS compared to SVD 
(instrumental deliveries were excluded from analyses) was 10 % and 22 %, 
respectively, leading to an OR of 0.40 (95 % CI 0.29 – 0,54). There were 
significant differences in urge UI (OR 0.46, 95 % 0.25 – 0.86) and mixed UI 
(OR 0.23, 95 % CI 0.05 – 0.95) among primiparous women after CS compared 
to SVD. Pooled prevalences from two cohort studies [Farrell 2001, Hannah 
2004] on any UI did not show significant differences between any CS and SVD 
(0.74, 95 % CI 0.54 – 1.01) [Press 2007]. Also, when only severe UI was 
investigated there was no significant risk difference between CS and SVD 
[Press 2007].  
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Farrell et al [Farrell 2001] studied primiparous women 6 months postpartum in 
a cohort study. Women delivering by vaginal delivery had significantly higher 
risk of any UI compared to women delivering by CS (RR 2.8). There is, 
however, inconsistency in the literature. Groutz et al [Groutz 2004] found no 
difference in prevalence of any UI when comparing all CS to vaginal delivery. 
But when comparing elective CS (3.4% UI) to vaginal delivery (10.3 % UI) 
among primiparous women 1 year postpartum the difference was significant.  
In a cohort study, Wilson et al [Wilson 2002] investigated risk of any UI 4 – 7 
years postpartum among primiparous women. They found no significant 
protection against UI after the first CS compared to vaginal delivery, but they 
found a 15 % reduction of UI after  2 CS. Results from a recently published 
12 year cohort show that risk of UI after 2 CS is significantly reduced 
compared to SVD even 11 years after last birth. A combination of CS and SVD 
does not lead to a significantly reduced UI risk compared to SVD [MacArthur 
2011]. In the systematic review on cohort studies with a follow up time of > 1 
year, the protective affect of CS remained for stress and mixed UI [Press 
2007].  
The effect of CS and SVD on prevalence of UI during a short and long time 
period is rather clear, but the clinical significance is still unclear. Current 
evidence does not support routine use of elective CS to prevent UI. Several 
studies on UI and mode of delivery are not primarily designed or powered to 
explore this issue. Lack of focus on timing of CS, influence of instrumental 
delivery, adjustments for age and parity are some of the factors affecting the 
results. There is still need for new prospective cohorts to investigate the effect 
of mode of delivery on UI and take time point, phase of birth, planned or not 
planmed CS into account, and to clarify whether certain conditions or groups 
are more prone to the protective effect of CS on UI postpartum.  
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1.5.2 Why less UI after CS compared to SVD? 
Vaginal delivery is the physiological mode of delivery. Despite this, it may be 
associated with significant short and long term complications. During delivery, 
prolonged pressure from the baby’s head on the pelvic floor may cause 
neuropraxia. The nervous pudendus is particular vulnerable to damage. As the 
baby passes through the vaginal canal, a variety of traumas to muscles, 
fascias and connective tissues affect the pelvic floor and urethral support, 
which are all associated with UI [Handa 1996]. Damage to the pelvic floor 
might occur after the distention during the active second stage of labor 
[Chaliha 2009], and damage increases with prolonged second stage of labor, 
episiotomy, forceps delivery, and increased fetal size [Wax 2004]. Women with 
elective CS will not experience these injuries.  
One ultrasound study found a larger levator hiatus area and increased bladder 
neck mobility among women with vaginal delivery compared to CS [Toozs-
Hobson 2008]. In another study researchers used ultrasound and cotton swab 
test to assess urethral profilometry and vesical neck mobility. Incident UI after 
the first SVD was associated with lower maximal urethral closure pressure and 
vesical neck mobility [DeLancey 2007] 
Deindl et al found that electromyography of the muscle activity in the pelvis 
was similar in continent nulliparous women and incontinent parous women 
with the exception of asymmetric and uncoordinated activity pattern in the 
levator muscle among parous incontinent women, which affects the continence 
mechanisms [Deindl 1994]. Concentric electromyography and pudendal nerve 
conduction studies have found an association between degree of denervation 
injuries and multiparity, fetal head size, forceps and long second stage of 
delivery [Allen 1990, Snooks 1984]. 
A cohort study examined 200 nulliparous women in pregnancy and postpartum 
[Dietz 2005]. By flowmetry, ultrasound of residual urine and bladder neck 
mobility the authors found that voided volume decreased in pregnancy and 
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increased again postpartum. Maximum flow rate increased in pregnancy and 
continued to increase postpartum. These findings correlated significantly with 
changes in several parameters of bladder neck mobility. There were, however, 
no significant differences postpartum among women who delivered by CS or 
SVD. Several other studies have also not been able to confirm urodynamic 
differences between women delivering by vaginal delivery or CS [Chaliha 
2002, Guarisi 2002, Leijonhufvud 2011].   

1.6  Incident UI in pregnancy as a risk factor for UI postpartum 
UI postpartum can start before pregnancy, or occur for the first time in 
pregnancy or after delivery. Accroding to one study, about 65 % of all women 
with UI during their life will recall that their UI started up either in pregnancy or 
postpartum [Handa 1996]. Women with UI before pregnancy are nearly 3 
times more likely to have UI postpartum [Farrell 2001].  
UI in pregnancy appears to be associated with UI postpartum (Se also 1.4: 
What is a risk factor?). Few studies have investigated this association (Table 
6). When reanalyzing available data on primiparous women who were 
continent before pregnancy in previously published articles, ORs for UI 
postpartum among women who were incontinent in pregnancy compared to 
women who were continent in pregnancy vary from 1.7 to 7.8 during the 3 – 12 
month postpartum period (Table 6). In adjusted analyses on primiparous 
women, Dietz-Itza found incident stress UI in pregnancy to be the only 
independent predictor of stress UI 12 months postpartum [Diez-Itza 2010]. A 
study from USA enrolled primiparous women 6 – 9 months postpartum. The 
women were continent before pregnancy and had delivered by vaginal delivery 
[Thomason 2007]. The authors found, based on retrospective data, that 78 % 
of women who had UI 6 – 9 months postpartum leaked also in pregnancy. 
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Many authors have found that UI in pregnancy is an important predictor for UI 
also later in life [Altman 2006, Burgio 2003, Diez-Itza 2010, Foldspang 2004, 
Hvidman 2003, Schytt 2004, van Brummen 2007, Viktrup 2006]. Viktrup 
questioned a total of 278 primiparous women about lower urinary tract 
symptoms after their first pregnancy, and again 12 years later [Viktrup 2006]. 
Stress UI during the first pregnancy and postpartum period predicted an 
increased risk of having UI 12 years later. Foldspang found that 56 % of all 
cases of any UI 1 – 10 years postpartum could be attributed to incident UI in 
pregnancy [Foldspang 2004].  
It appears to be an association between (incident) UI in pregnancy and UI 
postpartum and later in life. Both the estimates and study designs vary a lot. 
Large prospective cohorts may investigate the association between incident UI 
in pregnancy and UI postpartum, and to further search for obstetric factors and 
treatment that might lower the associated risk.   
1.6.1 Why does incident UI in pregnancy persist? 
Causative mechanisms for incident UI after labour differ from UI that arise 
during pregnancy. Several attempts have been made to explain the 
associations between incident UI during birth and UI postpartum: duration of 
second stage of labour, episiotomy, vacuum and forceps delivery and 
increased fetal size. However, we know that women who have only delivered 
by CS still have a higher prevalence of UI than nulliparous women [Rortveit 
2003a]. There must be factors in pregnancy, apart from risk factors in 
association with delivery, which influence UI postpartum.    
Several theories can be put forward to explain the association between UI in 
pregnancy and UI postpartum:  
- UI that is incident in pregnancy (not in association with labour) might be due 
to stretching and distending of the pelvic floor in late pregnancy; resulting in 
functional and anatomical alteration in muscles, nerves and connective tissue. 
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If these effects lead to UI, and the pelvic injuries are not healed postpartum, UI 
is likely to persist. The mechanisms of connective tissue injury and repair in 
the pelvis are, however, poorly understood.  
- UI in pregnancy could be a sign of congenital poor quality of the connective 
tissue supporting the urethra and the bladder neck. Some women may have 
an inherent risk of UI that leads to UI in pregnancy.  
- It is known that collagen metabolism is modified in individuals with stress UI. 
Joint laxity increases in pregnancy, but it is unknown if it subsequently returns 
to pre-pregnancy levels [Schauberger 1996]. Researchers have found 
association between relaxin levels in pregnancy and UI postpartum [Tincello 
2003]. However, no association have been found between markers of collagen 
weakness (stria and joint hyper mobility) and risk of UI [Braekken 2009, 
Chaliha 1999].  
- Bladder neck hypermobility is associated with stress UI. Bladder neck 
hypermobility increases in pregnancy, and this is found to correlate with a 
significantly increased risk of postpartum UI [Dietz 2005]. Bladder neck 
hypermobility is further associated with SVD and instrumental vaginal delivery 
[Dietz 2005]; also this correlates with increased prevalence of UI postpartum. 
Pregnancy might be the last straw that leads to UI among women with 
potential bladder neck hypermobility 
Our insight into causal mechanisms for UI in pregnancy is still limited. It is 
therefore also difficult to explain the mechanisms behind persistent UI 
postpartum. The answer to why incident UI in pregnancy persists after birth is 
unclear.  
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1.7 The effect of UI status in pregnancy and mode of delivery on UI 
postpartum 
There is some confusion among health personnel about advocating elective 
CS to prevent UI [Groutz 2004, Handa 1996, Heit 2001]. There have been 
several innuendoes about which women that will benefit the most from CS.  
We know that prevalence of UI in the postpartum period is lower after CS 
compared to vaginal delivery [Milsom 2009, Press 2007]. We know that there 
is more UI postpartum among women who had UI in pregnancy. Is it 
reasonable to assume that some women will benefit more than others from a 
CS to prevent UI postpartum?  
There is only one article, nevertheless retrospective, presenting results 
stratified for continence status in pregnancy and then analysed on delivery 
parameters [Glazener 2006]. Glazener et al found (reanalysed) an OR 3.6 and 
2.6 for UI after vaginal delivery among women who were continent and 
incontinent in pregnancy, respectively. It is unclear if this risk difference was 
significant. The absolute risk difference indicates that women with UI in 
pregnancy maybe should be advised to undertake CS to reduce risk of UI 
postpartum.  
Generally, current evidence does not support the routine use of elective CS to 
prevent UI among any group of women [Lal 2003, Nygaard 2006]. New studies 
are however needed to clarify whether women with UI in pregnancy represent 
a group at higher risk of UI postpartum after vaginal delivery, and thereby 
should be recommended CS. To investigate how women with UI in pregnancy 
are affected by mode of delivery, we need results that are stratified for 
continence status in pregnancy and then analysed on delivery parameters. 
1.8 Weight and weight gain as risk factors for UI 
High weight and high BMI are established risk factors for UI at all ages both 
among men and women. The last 5 years several reviews regarding BMI and 
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UI have been published [Bart 2008, Greer 2008, Hunskaar 2008, Khong 2008, 
Subak 2009]. 
There are still many questions to be answer regarding weight as a risk factor. 
For instance; is BMI a better estimate than actual weight (kg), waist 
circumference or waist-hip ratio? Does the location of weight play a role? Is it 
only weight due to adiposity that leads to UI, or will muscles, oedema and 
pregnancy related weight also lead to UI? For how long must the weight have 
persisted to lead to UI? Is there a threshold weight? What are the 
mechanisms? Is weight an extraneous confounder for other risk factors? 
Chapter 1.8 will deal with problems and reflections on UI and weight that go 
beyond weight gain in pregnancy.  
I will like to use an example to illustrate some of my points; Imagine a 
continent woman puts on a 20 kg backpack. How will this influence her risk of 
UI?  
1.8.1  What do we know? 
BMI is an established risk factor for UI. Both cross sectional studies 
[Hannestad 2003, Hunskaar 2004, Melville 2005] and longitudinal studies 
[McGrother 2006, Mishra 2008, Phelan 2009, Townsend 2007] have found an 
association between high weight and UI. Generally, overweight leads in 
general to an OR for UI of 1.5 – 3.0 compared to normal weight women, while 
obesity leads to an OR of 3.0 – 5.0.  
Several cross sectional studies have found a dose response relationship 
between BMI and UI [Danforth 2006, Han 2006, Hannestad 2003, Larrieu 
2004, Melville 2005]. The response relationship indicates that here might be a 
linear association between BMI and UI. RCTs on weight loss among obese 
women have found decreasing prevalence of UI after increasing weight loss 
[Brown 2006]. 
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The severity of UI, estimated by Sandvik’s severity index [Sandvik 2006] and 
other severity indexes based on frequency and volume escalates with 
increasing BMI [Danforth 2006, Hannestad 2003, Kuh 1999, Melville 2005, 
Sampselle 2002]. Townsend et al reported that the OR for severe UI increase 
with 3% for every kg weight gain [Townsend 2007].  
1.8.2 What is unclear? 
Type of study 
Our woman puts on a 20 kg backpack. We ask her; “Are you incontinent?” Her 
answer will only be associated with the backpack if she reports incident UI. To 
say anything about the association between UI and weight, weight gain, 
threshold weight, induction time and so on, our outcome should be incidence 
of UI. The majority of epidemiological studies analysing BMI and UI are cross 
sectional and thereby report only prevalence of UI [Buchsbaum 2002, Chiarelli 
1999a, Corcos 2004, Fultz 1999, Hannestad 2003, Hunskaar 2004, Kuh 1999, 
Melville 2005, Roe 1999, Rohr 2005, Simeonova 1990]. Several cohort studies 
have studied BMI and UI, but few reported data on incident UI according to 
BMI [Byles 2009, Mishra 2008, Townsend 2007]. One retrospective study has 
reported incidence of UI according to BMI [Santaniello 2007]. As it is very 
difficult to perform an RCT on weight gain, results from cohort studies are 
probably as far as we get.  
What is “weight”?
Weight or weight gain? 
If our woman at time point A does not wear a backpack, but at time point B 
wears a backpack, she will have experienced a weight gain during the A-B 
period. Her risk of UI at time point B can be associated with her weight at time 
point B or her weight gain during A-B. Weight and weight gain are two sides of 
the same story. Weight can be registered as a single static data point as in a 
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cross sectional study, while weight change is a dynamic variable relying on 
several observations; as in a cohort study.  
Few studies have investigated the association between weight gain and UI 
[Mishra 2008, Townsend 2007]. The Nurses Health Cohort Study found that 1 
kg/m2 weight gain increased the risk of frequent UI with 7% [Townsend 2007]. 
The results indicate that here is a linear association, not only with absolute 
weight and UI, but also between weight gain and UI.  
BMI vs. kg 
BMI is estimated by weight (kg)/height (m)2. The statistician Keys’ introduced 
BMI in 1972 [Keys 1972]. BMI was explicitly cited by Keys as being 
appropriate for population studies, and inappropriate for individual diagnosis. If 
our woman puts on a 20 kg backpack, her increased BMI will not reflect the 
added weight and increased risk of UI, as her height2 will partly camouflage 
the added weight. Most epidemiological studies use BMI when considering the 
association between weight and UI. Still, some studies find an explicit 
association between high weight measured in kg, not BMI [Townsend 2007]. If 
weight leads to UI through a mechanical process in the pelvis [Bump 1992], 
the absolute weight (kg), and not the relative weight (BMI) is interesting.  
What does BMI represent? 
BMI is a measurement of relative weight, a surrogate measurement with no 
indication of body composition. Does it matter if the weight gain is due to a 
backpack, pregnancy, muscles, oedema or adiposity? Many studies confirm 
the relationship between high BMI due to adiposity and UI. Weight gain in 
pregnancy is mainly due to a growing foetus, placenta and uterus, enlarged 
breasts and oedema. Weight gain appears to have a different impact on UI in 
pregnancy (Table 7) than in other time periods of life. There are no studies 
investigating whether a BMI due to muscles also might lead to UI. When 
Arnold Schwarzenegger won Mr Olympia he had a BMI of 31. Athletes have a 
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higher mean diameter of the perineal muscle [Kruger 2007]. Even thought 
athletes also leak, higher mean perineal diameter might be protective of UI 
[Stav 2007]. They sometimes gain the pelvic characteristics found among 
women with stress UI, but without having UI [Kruger 2007]. It is likely that high 
weight leads to UI mainly through adiposity, but studies are needed to 
investigate the association between a study population with high muscle mass, 
a study population with oedema or a pregnant study population and UI. 
Location of weight gain 
Will the risk of UI be the same if our woman puts the backpack on her back, 
abdomen or around her waist? Several studies have reported that waist 
circumference was predictive for stress UI [Hannestad 2005, Townsend 2008], 
even after adjusting for BMI [Han 2006, Hannestad 2005]. Another small 
cohort study found that reduction in waist circumference explained the effect of 
reduced BMI on UI [Subak 2005]. Waist – hip ratio is also found to be an 
independent risk factor for stress UI [Brown 1999, Hannestad 2005]. Studies 
on pregnant women have found that weight gain during pregnancy is not 
associated with UI (Table 7). This might indicate that pressure directly on the 
pelvis predicts UI while weight with a vector that does not put direct pressure 
on pelvis (a backpack, a large pregnant abdomen, leg oedema, etc) might not 
predict UI. 
Weight period
If our woman puts on an open backpack that gradually fills up with 20 kg 
rainwater, will she experience the same risk of UI as if she puts on a 20 kg 
backpack at once? Few studies have investigated the association between UI 
and the exposure time of the measured weight (Figure 1).  
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Figure 1. Exposure time and induction time of weight in the association with UI 
Time point 
1: 
BMI 
Exposure time of 
weight 

Time point 
2: 
BMI 
Induction 
time? 

UI?
Exposure time and speed of weight gain 
Mishra et al found that women who had been overweight from age 26 – 54 
were more likely to be incontinent than women who became overweight after 
the age of 54 [Mishra 2008]. Several articles present results indicating that a 
large weight gain in pregnancy does not lead to UI [Diez-Itza 2009, Eason 
2004]. Is it possible that weight gain must have persisted for a certain time 
(more than 9 months?) to lead to UI?  
Another aspect is how fast the weight increases. Townsend et al reported an 
OR 1.9 for UI among women who gained > 30 kg over 28 years, an OR 2.5 
among women who gained > 30 kg over 12 years and an OR 3.5 among 
women who gained > 20 kg during 4 years [Townsend 2007]. It appears that 
weight gain over a short time period increased the risk of UI more than weight 
gain over a long time period. If so, why does not weight gain in pregnancy lead 
to UI? 
Induction time  
If our woman puts on the 20 kg backpack this morning, she will probably not 
be incontinent this evening. It will take some time to develop UI; there will be 
an induction time from the exposure “weight gain” to manifestation of the 
outcome “UI” (Figure 1).  
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SVD is an example of a risk factor for UI with a short induction time. Childhood 
enuresis has a long induction time as it increases risk of incident UI among 
adult women [Brown 2010]. In cross sectional studies on BMI and UI there is 
no information about induction time. Cohort studies have a time period 
between BMI and UI. We do, however, not know if this represents the whole 
induction time.  
Will high weight during the induction time induce physiological changes in the 
pelvis that take time to bring out into clinical symptoms? One author claims 
that overweight stress the pelvic floor through a statistically significant change 
in measures of intra-abdominal pressure [Noblett 1997]. Increasing intra-
abdominal pressure is linear with weight, and pressure is reduced by weight 
loss. This indicates no induction period between weight gain and UI. We are, 
however, not sure that intra-abdominal pressure is the only link between 
overweight and UI. Other processes might be slow acting, like chronic strain, 
stretching and weakening of the muscles, nerves, ligaments and other 
structures of the pelvic floor etc but few studies have been able to demonstrate 
this [Milsom 2009]. The biological cause for weight to lead to UI might indicate 
the induction time.  
Weight as an extraneous/confounding risk factor
Figure 2. Extraneous risk factors for the association between weight and UI. 
High weight 
Extraneous risk factor
Chronic disease 
Hormonal changes 
Social status 
Food 
 UI 
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Weight or chronic disease 
Will our woman develop arthritis and therefore later develop UI? High BMI is 
related to several chronic diseases; hypertension, diabetes, coronary disease, 
stroke, asthma, arthritis, depression, cancer and neuropathy. Several of these 
diseases are also associated with UI; hypertension [Song 2005], coronary 
heart disease [Shakir 2007], asthma [Phelan 2009], arthritis [Phelan 2009] and 
depression [Phelan 2009, Sung 2009]. Some diseases, like diabetes and 
stroke, are still risk factors for UI even after adjusting for BMI [Byles 2009, 
Ebbesen 2009]. People with UI will in general report lower health status than 
people without UI [Roe 2000]. Can disease itself cause UI, and not the weight? 
(Figure 2) Asthma might lead to coughing, diabetes might lead to neuropathy, 
stroke might lead to autonomic damage that influence continence, 
hypertension and coronary heart disease might indicate cardiovascular 
disease in pelvic region. Studies that have data on these diseases ought to 
take these factors into consideration when investigating the relationship 
between weight and UI.  
Weight or weight related hormonal changes 
Will our woman with the backpack gradually develop UI due to hormonal 
changes in the body? Adiposity leads to different levels of several hormones; 
increased levels of cortisone, insulin, leptin, relaxin and reduced levels of FSH, 
LH, inhibin B, SHBG and testosterone. Most studies confirm that estradiol 
levels increase with high BMI [Karim 2009], but results are not consistent [De 
Pergola 2006]. These hormones influence the body in several ways.  
Some studies have found estradiol levels to be a risk factor for UI, even after 
adjusting for BMI [Gopal 2008, Teleman 2009]. Also, studies have found no 
association between estradiol and UI [Litman 2007, van Geelen 1982], while 
others have found a protective effect [Thielemann 2009]. Studies have found 
no association between increased levels of cortisone, testosterone [Teleman 
2009] or SHBG [Litman 2007] and UI. Data on UI and relaxin are unclear 
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[Kristiansson 2001]. Weight influences hormone levels. We do not know the 
mechanisms for these hormonal changes to lead to UI. We cannot rule out that 
UI is caused by endocrine changes rather than by adiposity itself (Figure 2). 
Future studies with bio bank data are needed to investigate these associations 
further.   
Weight or social status 
Will a woman who carries all her belongings in a backpack have higher risk of 
UI due to factors associated with low social status? Low social status has been 
found to be associated with UI [Karakiewicz 2008]. The other way around, UI 
has also socioeconomic implications [Temml 2000]. Low social status is 
associated with several characteristics: smoking, higher alcohol consumption, 
low educational level, low income and unemployment, race, marital status, 
more children, less physical activity and poor self reported health. Overweight 
is also a larger problem among people in lower social classes. All the above 
characteristics of low social class are in studies found to be associated with UI, 
but there is no consistency in the literature. It is difficult to find biological 
explanations for several of these findings. Some studies find that the above 
characteristics are risk factors even after adjusting for BMI. Unfortunately, 
most studies investigating the association between BMI and UI do not take 
variables associated with social status into account. There is need for further 
studies on weight and potential confounders. We can not rule out that 
socioeconomic status have a role in UI, and that BMI and social status interact 
as risk factors (Figure 2).  
Weight or food 
Is it the weight of the backpack or what you put in the backpack that leads to 
UI? There is a close relationship between unhealthy saturated fatty food and 
adiposity. Intake of total fat and saturated fatty acids is linked to increased risk 
of stress UI after adjusting for BMI [Dallosso 2004]. This indicates that there 
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might be an association between certain components in the diet and the onset 
of UI (Figure 2). The mechanisms behind this finding are, however, unclear.  
BMI and pregnancy
Many studies have found pregnancy per se to be a risk factor for increased 
prevalence of UI both in pregnancy [Hojberg 1999] and several years later 
[MacLennan 2000, Rortveit 2003a]. A general theory is that the increased UI in 
pregnancy is due to weight gain [Milsom 2009]. However, previous studies 
indicate that the increased incidence of UI in pregnancy is not due to weight 
gain [Chiarelli 1997, Diez-Itza 2009, Eason 2004, Glazener 2006, Kristiansson 
2001, Pregazzi 2002, Sottner 2006, van Brummen 2007] (Table 7).  
Weight gain in pregnancy is normal 
Will our woman have lower risk of weight induced UI if she puts on the 
backpack while she is pregnant? No studies have been designed to 
investigate the association between weight gain and UI in association with 
pregnancy. However, studies dealing with this association have not found a 
clear association, neither with UI in pregnancy nor postpartum (Table 7).  
Pregnancy is a normal physiological state for women, necessary from an 
evolutionary point of view. Overweight, however, is not. Pregnancy affects the 
female body in several ways; both mechanically, psychologically and last but 
not least hormonally. A hypothesis is that weight gain in pregnancy is not 
associated with UI due to other pregnancy related changes. Some studies 
have found oestrogen to have a protective effect on UI [Thielemann 2009]. 
Oestrogen levels increases markedly during 3rd trimester. Some studies have 
found no association, and even negative associations, between oestrogen 
levels and UI [Hendrix 2005]. These levels of oestrogen in the latter studies 
were, however, much lower than what is normal in pregnancy.  
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We do not know the answer to why there is no association between weight 
gain and UI in pregnancy and postpartum. Maybe there are two weight gain 
stories: one for pregnant women and one for everyone else? Also, we do not 
know exactly why UI peaks in pregnancy. There is need for studies designed 
to investigate this association. 
What type of UI is associated with high weight?
If our woman puts on a 20 kg backpack; is she more prone to stress UI than 
urge UI? Stress UI is the type UI most closely associated with high weight 
[Alling Moller 2000, Hannestad 2003, Mommsen 1994]. It does not appear to 
be such a close association between high weight and urge UI. When looking at 
the dose response association, results are, however, not consistent. Cross 
sectional studies have investigated the association between weight and UI. In 
several studies, all involving > 1000 participants, the dose response 
association for type of UI for every 5 unit BMI varies; some studies find a 
stronger association between stress UI than urge UI [Hannestad 2003, 
Jackson 2004, Song 2005]. One study found an even risk for stress UI and 
urge UI [Brown 1999]. Finally, one study found a stronger association for urge 
UI than stress UI [Kuh 1999].  
Some cohorts have investigated the association between weight and type of 
UI. Studies confirm that stress UI is more strongly associated with high weight 
than urge UI [Burgio 2007b, Dallosso 2003, Mishra 2008, Phelan 2009, 
Townsend 2008, Townsend 2007, Waetjen 2007]. However, also in cohort 
studies the results are not uniform. A large study on weight and UI found that 
BMI was associated with urge and mixed UI, but not stress UI [Townsend 
2008]. Even thought the general impression is that high weight leads to mainly 
stress UI, results are not consistent.  
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1.8.3 Conclusion on weight and weight gain 
Although few would doubt that weight plays a role in UI, it has been difficult to 
demonstrate exactly how it acts. Today’s knowledge tells us that there are 
associations between weight and any UI and severity of UI, and the strength of 
the association increase with high weight.  
There are still many unanswered questions for future studies on UI and weight: 
What does a high BMI represent: muscles, pregnancy, oedema or body fat? Is 
only adiposity linked to UI? Is BMI the best variable for the association with UI, 
or is location of weight measured by waist-hip-ratio, waist circumference, total 
body fat, or visceral fat better variables? There is need for prospective studies, 
preferably lifelong studies with several follow-ups, investigating the duration 
and induction time of weight and weight gain’s association with incident UI. 
Overweight are associated with several conditions, social characteristics, 
distinguished food intake, and hormonal changes. Studies should try collect 
these (biological) data and take these variables into account when analysing 
on UI. Outcome of future studies on weight and UI should differentiate 
between the types of UI.  
The hypothesis on BMI and UI is likely to be elaborated upon in future studies 
on weight and UI.  
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2. The present study 
2.1 Aims of the study 
The aims of the present study were to investigate incidence, prevalence and 
risk factors for UI in a cohort of pregnant women. 
- Sub study I.   
The aims of this study were to investigate incidence and prevalence of UI in 
pregnancy, in addition to investigate associated risk factors for UI in 
pregnancy. Results are presented in Paper I.  
- Sub study II.  
The aims of this study were first to investigate the incidence and prevalence of 
UI 6 months after delivery; second, to investigate the impact of continence 
status in week 30 of pregnancy on UI 6 months postpartum and third, to 
investigate how mode of delivery may interact with continence status in 
pregnancy to increase or reduce the risk of UI 6 months postpartum. Results 
are presented in Paper II.  
- Sub study III.   
The aim of this study was to investigate how the incidence of UI in pregnancy 
was affected by weight gain in pregnancy. We also investigated how incidence 
and prevalence of UI 6 months postpartum were affected by weight changes in 
pregnancy and postpartum. Results are presented in Paper III.  
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2.2 Material and methods 
2.2.1 The Mother and Child Cohort Study 
The present study is based upon data from The Mother and Child Cohort 
Study (MoBa). The superior goal for The MoBa study was to achieve better 
health for mothers and children in the future, primarily through prevention. The 
background for the MoBa study was the lack of understanding about the cause 
of disease in association with pregnancy. Among many things, the MoBa was 
carried out with the intention to aid the development of new medicines through 
new methods in genetic epidemiology, to reduce unwarranted anxiety among 
pregnant women, to examine quality of life and positive aspects of health, and 
to examine commonly held beliefs concerning the causes of disease [Magnus 
2005].  
The MoBa project was initiated by MBRN in Bergen and the Norwegian 
Institute of Public Health in Oslo. The MoBa study was anchored at The 
Norwegian Institute of Public Health, Division of Epidemiology, which also 
includes MBRN located in Bergen [Magnus 2005].  
There are approximately 60,000 births in Norway annually. To test specific 
hypotheses about the cause of a number of diseases, the target sample size 
of MoBa was 100,000 pregnant women who were to be recruited nationally 
between 1999 and 2006. Due to lower response rates than expected (45 %), 
100,000 women were before the summer of 2009.   
An invitation for participation in the study was sent to women at their home 
address. The majority of pregnant women received this package 3 weeks 
before attending routine ultrasound examination in week 17 of pregnancy 
(Figure 3). A total of 39 of about 50 hospitals and maternity units in Norway 
with more than 100 births annually participated in the study. Names and 
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addresses of pregnant women were obtained from the maternity unit that had 
received a request for ultrasound examination. 
Figure 3. Questionnaires in the Mother and child cohort study used in our 
study [Magnus 2005] 
Responsible insititution 
:  
Week/mth Hospital MBRN Inst.of 
public 
health 
10 – 14 
(Before ultrasound)
Received name and 
address of pregnant 
women from referring 
GP.  
A copy of list sent to 
MBRN each week 
Sends invitation by post to women 
with Questionnaires 1 and 2.  
Receives consent form and 
questionnaires from participating 
mothers and fathers.  
17 
(Ultrasound 
examination) 
Women are asked if 
they will participate. 
Blood sample taken.  
Receive copy of standard 
ultrasound form 
Receive blood 
sample from 
mothers and 
fathers.  
18 – 33 
(later in pregnancy)
 Reminder fro missing consent form 
and Questionnaireionnaires. 
Send out Questionnaire 3 in week 
30 
Reminder sent 3 weeks later 
Birth Blood sample from 
mother and umbilical 
cord after birth 
Receive blood 
sample from 
mother and 
child 
6 months post 
partum 
 Send out Questionnaire 4  
Each week the ultrasound clinics sent a list of all women who had 
appointments to the MBRN. The invitation, which was sent out in collaboration 
with each participating hospital, described the purpose of the study, protection 
of privacy and practical details. It was emphasized that participation was 
voluntary. The women were also notified that they could withdraw at any time. 
Information brochures about the project and the MBRN were enclosed, 
together with Questionnaire 1 and 2 (Figure 3). Also enclosed was a consent 
form, which required a signature, and a return-paid envelope. If the women 
accepted to participate in the MoBa, six future Questionnaires to mother 
and/or father and one blood sample from mother, father and child was 
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collected. Questionnaire 3 was sent out in week 30 of pregnancy, 
Questionnaire 4 was sent out 6 months post partum (www.fhi.no). Papers I – 
III are based upon Questionnaire 1, 3 and 4. Further questionnaires regarding 
mother and child’s health were sent out 18 and 36 months post partum. 
Questionnaires on child’s health only were also sent out when the child was 5 
and 7 years old.  
Images of the returned questionnaires were scanned. A database was 
constructed for each of the questionnaires. A working group carried out quality 
controls during and after the scanning process and before final storage, and 
made sure manual entering of specific variables was carried out if required. 
Questionnaires having passed through the quality control were stored in the 
databases. Files intended for use by researchers for analysis, were given out 
in SPSS format [Magnus 2005]. 
The MoBa information from questionnaires and blood samples were linked to 
medical registries. No intervention was undertaken in the MoBa study. MoBa 
was open for researchers from both basic and applied research. The focus for 
research on MoBa data could be child, birth or mother. We focused on the 
mothers.  
In Paper I, available dataset at the time (April 2006) that included 
Questionnaire 1 and Questionnaire 3 were used. All women who had 
contributed with more than one pregnancy were excluded (n=2,983). Paper I
was based on a sub study dataset of 43,279 women.  
Paper II and Paper III use the same dataset. This time the study population 
was restricted to women who had answered Questionnaire 4 in addition to 
Questionnaire 1 and 3. In addition, we excluded all parous women and all 
women who were incontinent before pregnancy. Women who did not report 
continence status before pregnancy were also excluded. Paper II and Paper
III are based on a sub study dataset containing 12,679 women (Figure 4).  
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Figure 4. Participants in Paper I, Paper II and Paper III
Datafile of women enrolled once in the MoBa study 
1999 – 2006
43,279 (Paper I)
Nulliparous women
19,981
Women who were urinary continent before pregnancy
16,268
Women who answered Questionnaire 1, 3 and 4 and 
were included in the study
12,679 (Paper II and III)
Paorus women
23,298
Women who were urinary incontinent before pregnancy or 
women with missing incontinence status before pregnancy
3,713
Women who did not answer Questionnaire 1, 3 and 4
3,589
In October 1996, the project was granted a concession by the Norwegian Data 
Inspectorate. This was renewed in September 2003. The project is partly 
financed by the Ministry of Health and has been approved by the Norwegian 
Parliament.  
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2.2.2  The Medical Birth Registry of Norway 
The MoBa data was linked to MBRN, which holds information on all births in 
Norway from 1967. All maternity units in Norway report name, personal 
identification number and several data regarding mother’s health before and in 
pregnancy, data regarding delivery and possible complications during labour, 
and data on the child on a notification form which is sent to the MBRN 
(Appendix 4). The dataset from MBRN was included in the data we received 
from MoBa. If the MBRN did not have information on previous births, the 
women were defined as nulliparous and included in this study. 
2.2.3 Questionnaires  
The women received a 14 – 18 pages questionnaire in week 15, week 22 
(focus on diet) and week 30 of pregnancy, 6 months postpartum, 18 months, 3 
years, 5 years (sent out for the first time in 2010) and 7 years after birth. The 
latter questionnaires focus mainly on the child. In addition, the father received 
a questionnaire in week 15. Mother gave blood and urine sample at ultrasound 
examination; father gave a blood sample at the same time. At birth a blood 
sample was taken from mother and from the umbilical cord of the baby to be 
stored in the bio bank.  
In Paper I we used questionnaire data from questionnaires received in week 
15 (Questionnaire 1) and 30 (Questionnaire 3). In Paper II and Paper III we 
used questionnaire data from Questionnaire 1, Questionnaire 3, in addition to 
data from Questionnaire 4 sent out 6 months postpartum (Figure 4). (See 
appendix 5 – 7 for questions with UI variables, see 
“http://www.fhi.no/eway/default.aspx?pid=233&trg=MainArea_5661&MainArea
_5661=5631:0:15,2301:1:0:0:::0:0&MainLeft_5631=5544:42547::1:5641:1:::0:0
” for full questionnaires (or use the following navigation: www.fhi.no, choose 
“mor og barn-undersøkelsen”, choose “Spørreskjemaer”)).   
In Questionnaire 1 (Appendix 5), only question 39 was dedicated UI:  
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“Did you have UI before pregnancy?” yes/no. Questions about UI before 
pregnancy in Questionnaire 3 also contained data on type, frequency and 
amount. Therefore data on UI before pregnancy was taken from Questionnaire 
3.  
In Questionnaire 1, we used question 37 regarding weight: “What was your 
weight when you became pregnant, and what is your weight now?” 
In Questionnaire 3 (Appendix 6), question 28 was dedicated UI:  
1) “Before this pregnancy, did you experience incontinence when coughing, 
sneezing or laughing?” Answering alternatives were; “yes”/”no”. Frequency 
alternatives: “1-4 times a month”, “1-6 times a week”, “Once a day”, “More than 
once a day”. Amount alternatives: “Drops”, “Large amounts”.  
2) “Before this pregnancy, did you experience incontinence during physical 
activity (running/jumping)?” Answering alternatives were; “yes”/”no”. 
Frequency alternatives: “1-4 times a month”, “1-6 times a week”, “Once a day”, 
“More than once a day”. Amount alternatives: “Drops”, “Large amounts”.  
3) “Before this pregnancy, did you experience incontinence with a strong need 
to urinate?” Answering alternatives were; “yes”/”no”. Frequency alternatives: 
“1-4 times a month”, “1-6 times a week”, “Once a day”, “More than once a 
day”. Amount alternatives: “Drops”, “Large amounts”.  
Question 1-3 was repeated, starting with “In this pregnancy, have you 
experienced…..” 
In Questionnaire 3, we used question 25 regarding weight: “How much did you 
wheigh at your last antenatal check-up?” 
In Questionnaire 4 (Appendix 7), question number 54 regarding UI was 
phrased the same way as questions regarding UI in Questionnaire 3.  
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In Questionnaire 4, we used question number 69 regarding weight: “How much 
did you weigh at the end of your pregnancy, and how much do you weigh 
now?  
The UI questionnaires currently used in MoBa were changed after we received 
our present data file. The current questionnaires presented at the web are not 
all expressed and typed in the same way as the attached files in the Appendix, 
which are the questionnaires used in the current study.  
The definition of any UI in Paper I – III was based on the above questions. All 
women who answered conformingly on the UI questions, and/or reported 
frequency of UI and/or reported amount of UI were defined as urinary 
incontinent in Paper I – Paper III.  
2.2.3 Analyses  
The MoBa dataset was primarily analysed in SPSS. STATA was used for log 
binomial regression analyses.  
A variable was included in multivariable regression analyses as a confounder if 
the variable affected both the prevalence of the exposure and the outcome, 
and made a difference to the risk of UI associated with the exposure. We 
explored age, BMI, sex of baby, head circumference, baby’s weight, Apgar 
score (1 and 5 minutes), fetal presentation at delivery (normal occipital, 
breech, transverse, abnormal fetal head presentation and other), birth time 
(minutes), prolonged labour, perineal tear grade 3–4 and induction 
(amniotomy, oxytocin and prostaglandins), training, and breastfeeding.  
Effect modification of continence status on the effect of SVD compared with 
elective CS on UI was tested by use of interaction terms in multivariable 
logistic regression analyses in Paper II. 
Paper I presents risk parameters as OR. In Paper II all ORs and 
corresponding CI were converted to RRs and corresponding CI by use of the 
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formula RR = OR/((1 – P) + (OR x P)) [Zhang 1998]. In this formula, P is the 
prevalence of UI in the unexposed group. In Paper III log binomial regression 
analyses were used to present risk parameters as RR.  
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3 Main results 
3.1 Paper I 
Wesnes SL, Rortveit G, Bo K, Hunskaar S. (2007), Urinary incontinence in 
pregnancy. Obstet Gynecol, 109: 922 – 928. 
Aim: Investigate incidence and prevalence of UI in pregnancy, and investigate 
risk factors associated with UI in pregnancy. 
We used questionnaire dataset available from MoBa at the time, containing 
43,279 women (response rate 45%) by week 30 of pregnancy. We reported 
data on any UI, in addition to type, frequency, and amount of UI. Potential risk 
factors were investigated by logistic regression analyses. 
The mean age at the time of filling in Questionnaire 3 was 29.5 (range 14–47) 
years. The mean number of deliveries before the present pregnancy was 0.8 
(range 0–10). The prevalence of UI increased from 26 % before pregnancy to 
58 % in week 30. The corresponding figures for nulliparous women were 15% 
and 48%, and for parous women 35% and 67%. The cumulative incidence was 
46%. In week 30, 31 % of nulliparous and 42 % of parous women experienced 
stress UI. The majority of pregnant women experienced only minor frequency 
and amount of leakage. Parity was a strong and significant risk factor for UI in 
adjusted analyses both before pregnancy (OR 2.5, 95% CI 2.4 –2.7 for 
nulliparous and OR 3.3, 95% CI 3.1–3.5 for multiparous women) and in 
pregnancy (ORs 2.0, 95% CI 1.9 –2.1 and 2.1, 95% CI 2.0 –2.2, respectively). 
Age > 26 years and BMI > 20 kg/m2 were weaker, but still statistically 
significant, risk factors. 
We concluded that the prevalence of UI increases substantially in pregnancy. 
UI both before and in pregnancy was associated with parity, age, and BMI. 
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3.2 Paper II 
Wesnes SL, Hunskaar S, Bo K, Rortveit G. (2009), The effect of urinary 
incontinence status during  pregnancy and delivery mode on 
incontinence postpartum. A cohort study. BJOG, 116: 700 – 707.  
Aim: First to investigate the incidence and prevalence of UI 6 months after 
delivery; second, to investigate the impact of continence status in week 30 of 
pregnancy on UI 6 months postpartum and third, to study how mode of 
delivery may interact with continence status in pregnancy to increase or 
reduce the risk of UI 6 months postpartum. 
We used questionnaire data from nulliparous women who were continent 
before pregnancy who had answered Questionnaire 1 (week 15), 3 (week 30) 
and 4 (6 months postpartum). The study population thereby consisted of 
12,679 of the women from Paper I. Data was linked to MBRN. Mode of 
delivery was categorised as elective CS, acute CS intended as elective CS, 
acute CS intended as SVD, unspecified CS, SVD, forceps delivery and 
vacuum delivery. Confounding was thoroughly evaluated and adjusted for by 
multivariable logistic regression analyses and crosstabs analyses. Effect 
modification of continence status on the effect of SVD compared with elective 
CS was tested by Breslow – Day. We treated independent variables as 
categorical. Due to UI being a very common condition, all OR and CI were 
converted to RR. 
Mean age was 28 years (range 15–45 years), and mean BMI was 24.1 kg/m2 
(range 14–54 kg/m2). A total of 14 % of the study population had delivered by 
CS. UI was reported by 31% of the women 6 months after delivery. Incidence 
of UI 6 months postpartum among women who were continent before and in 
pregnancy was 21 %. Compared with women who were continent in 
pregnancy, UI was more prevalent 6 months after delivery among women who 
experienced UI in pregnancy (adjusted RR 2.3, 95% CI 2.2–2.4).  
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The strongest associated factors for incident UI in adjusted analysis were 
forceps delivery (RR 4.0, 95% CI 2.6–5.8), SVD (RR 3.2, 95% CI 2.1–4.7), 
vacuum delivery (RR 3.2, 95% CI 2.1–4.7), all compared with elective CS. The 
different types of CS did not represent significant risk factors for UI 6 months 
postpartum. Compared with elective CS, the adjusted RR for UI 6 months 
postpartum after SVD was 3.2 (95% CI 2.5–3.9), after vacuum 3.3 (95% CI 
2.6–4.0), and after forceps 3.5 (95% CI 2.6–4.4).  
Adjusted RR for incontinence after SVD compared with elective CS was 3.2 
(95% CI 2.2–4.7) among women who were continent and 2.9 (95% CI 2.3–3.4) 
among women who were incontinent in pregnancy. By Breslow-Day we did not 
find statistically significant difference in the risk estimates.  
We concluded that there was a considerably raised risk for UI postpartum 
among those who developed UI in pregnancy compared with those who were 
continent. The association between incontinence postpartum and mode of 
delivery was not substantially influenced by incontinence status in pregnancy. 
Prediction of a group with high risk of incontinence according to mode of 
delivery cannot be based on continence status in pregnancy. 
3.3 Paper III 
Wesnes SL, Hunskaar S, Bo K, Rortveit G. (2010) Urinary incontinence 
and weight gain in pregnancy: a cohort study. Am J Epidemiol, 172: 1034 
– 1044
Aim: Investigate how the incidence of UI in pregnancy was affected by weight 
gain during weeks 0–15 and 15–30 of pregnancy. We also investigated how 
incidence and prevalence of UI 6 months postpartum was affected by weight 
gain during weeks 0–15, 15–30, 30–delivery, and 0–delivery; by weight gain 
from week 0 of pregnancy to 6 months postpartum; and by weight loss from 
delivery to 6 months postpartum.
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We used the same MoBa data material in Paper III as in Paper II; 12,679 
nulliparous women who were continent before pregnancy who had answered 
Questionnaires 1, 3 and 4. We categorised weight gain and weight loss into 1 
– 50 percentile, 51 – 90 percentile and > 90 percentile to investigate the effect 
of weight change beyond the median and also isolate the effects of extreme 
weight change. Data were stratified for underweight, normal weight and 
overweight women. We treated independent variables as categorical, whereas 
weight gain and weight loss were also treated as continuous variables in 
logistic regression analyses. We evaluated the assumption of a linear trend 
between weight change and UI through model comparisons using chi squared 
tests. The assumption of linearity could not be rejected (P = 0.65 for weight 
gain and P = 0.06 for weight loss). Adjustment for confounding was done by 
multivariable logistic regression for the different time periods. We used STATA 
for log binomial regression analyses in order to present risk parameters as 
relative risks. 
Mean weight change during week 0 – 15 was 3.3 kg, week 15 – 30 was 7.0 kg, 
week 30 – delivery 6.3 kg, week 0 – delivery 15.8 kg, week 0 – 6 months 
postpartum 1.2 kg and delivery – 6 months postpartum -14.5 kg. Weight gain > 
50th percentile during weeks 0–15 of pregnancy was weakly associated with 
higher incidence of UI at week 30 compared with weight gain  50th percentile, 
but not associated with UI 6 months postpartum. The effect of weight gain on 
UI led to the highest risks among underweight women.  
Weight gain > 50th percentile in pregnancy was not associated with increased 
prevalence of UI 6 months postpartum. Weight gain > 50th percentile and > 
90th percentile  from start of pregnancy to 6 months postpartum was more 
strongly associated with having UI than was high weight gain in any single sub 
period in analyses of all women (RR 1.2, 95% CI 1.1 – 1.2 and RR 1.3, 95 % 
CI 1.2 – 1.4, respectively). The same trend was found in stratified analyses. 
For each kg weigh gain from week 0 – 6 months postpartum, the RR of UI 6 
months postpartum increased by 2.3 % (RR 1.02, 95 % CI 1.02 – 1.03).  
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Weight loss > 50th percentile and > 90 percentile postpartum among women 
who were incontinent in pregnancy lead to a statistically significant risk 
reduction on UI (RR 0.9, 95 % CI 0.8 – 0.9 and RR 0.7, 95 % CI 0.6 – 0.8, 
respectively). The findings were reproduced among normal weight and 
overweight women. For each kilogram of weight loss from delivery to 6 months 
postpartum among women who had UI in pregnancy, the RR for UI decreased 
2.1% (RR 0.98, 95% CI 0.97, 0.99). Among women who were continent in 
pregnancy, the risk of incident UI 6 month postpartum also decreased with 
increasing weight loss (> 50th percentile RR 0.8, 95 % CI 0.7 – 0.9 and > 90th 
percentile RR 0.7, 95 % CI 0.5 – 0.8). Corresponding associations were found 
in stratified analyses among normal weight and overweight women.  
We concluded that weight gain in pregnancy does not seem to be a clinically 
important risk factor for UI. However, weight loss postpartum may be important 
for avoiding incontinence and regaining continence 6 months postpartum. 
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4 Discussion 
4.1 Methodological considerations 
As all papers originate from the same data material, I will discuss 
methodological considerations in a common chapter.   
4.1.1 Methodological strengths 
The MoBa study and the Danish National Birth Cohort [Jacobsen 2010] are 
considered the most comprehensive international pregnancy cohorts. The 
Danish National Birth Cohort and the MoBa started recruiting women in 1996 
and 1999 respectively, both aiming at enrolling 100,000 pregnant women. By 
2011 only MoBa has recruited 100,000 women.  
As the MoBa data file was linked to validated MBRN data, the database has 
unique possibilities to explore UI in association with pregnancy. The MoBa 
study invited all pregnant women in Norway to participate, underscoring that 
the target population of MoBa was unselected and population-based. Cohorts 
on UI in pregnancy and postpartum rarely exceed > 1,000 participating women 
[Brown 2010, Solans-Domenech 2010]. In 2006 Glazener wrote in their article; 
“With responses from around 3405 women who were primiparae, this is the 
largest study to date examining the relationship between onset of 
incontinence, pregnancy and other potential confounding factors.” [Glazener 
2006] By 2011 the study population in Paper I was the largest study 
population in cohorts on UI in pregnancy. Paper II and III was the largest 
cohorts based on nulliparous women.  
External validity 
External validity refers to whether or not the results can be generalised to a 
population beyond those who participated in the survey. High external validity 
is regarded as the main advantage of a population-based cohort studies as 
MoBa. The best way to be able to say something about everybody is to include 
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everybody. This is what MoBa intended to do. If MoBa had succeeded in 
including everybody, the external validity would be high.  
The MoBa study was intended as a population based study including all 
pregnant women from 50 out of 52 maternity units with > 100 birth/year in 
Norway. Nearly all pregnant women in Norway are referred to routine UL in 
week 18. All women who belong to the respective maternity units were invited 
to the study when referred to UL examination. 
Participation rates for epidemiologic studies have been declining 
internationally during the past 30 years with even steeper declines in recent 
years [Galea 2007]. It has been increasingly difficult to achieve high 
participation rates in cohort studies like MoBa. There may be many reasons for 
the low participating rate [Galea 2007]; for instance resistance to commitment 
in a comprehensive study with questionnaires of 16 pages. The response rate 
in MoBa in 2005 was 43 % [Magnus 2006]. By 2007, the recruitment rate was 
40 % (89,594/222,484). The recruitment rate dropped when invited the second 
time. Response rate was therefore somewhat higher for nulliparous women 
(45 %). The Danish National Birth Cohort, which has a similar design as the 
MoBa study, has an overall response rate of 31 % [Jacobsen 2010]. 
Selection bias due to low recruitment has to be addressed. MBRN has data on 
women who did not participate in MoBa. One study shows only minor 
differences in parity, age, preeclampsia, gestational age, preterm birth, birth 
weight and low birth weight between participating and non – participating 
women [Magnus 2006]. A recent study, however, conclude that there are 
statistically significantly relative differences in prevalence estimates between 
cohort participants and the total population for several variables; young age (< 
25), chronic hypertension and smokers, to mention some factors [Nilsen 2009]. 
Still, there is no reason to believe that there was a selection on the basis of UI 
status since the MoBa was a survey covering many topics, and UI questions 
only being a minor issue.  
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Still, women in lower socio-economic classes were underrepresented in the 
MoBa [Magnus 2006]. This is in line with results from the Danish National Birth 
Cohort [Jacobsen 2010] .The literature is inconsistent regarding the 
association between income, level of education and UI [Burgio 2007a, 
Torkestani 2009]. We cannot rule out that there was a selection bias arising 
from socioeconomic factors affecting our prevalence data. If there is a higher 
prevalence of UI among women with low income and low level of education, 
the incidence and prevalence estimates in our study were underestimated. 
Risk factors such as BMI, age and parity are likely to be distributed differently 
among women with low income as compared to women with higher income. 
However, a recent study from MoBa found no statistically relative differences 
in association measures between participants and the total population, and the 
authors concluded that effect estimates for risk factors were not affected by 
selection bias in the MoBa [Nilsen 2009]. We therefore believe that the 
presented risk estimates for UI are not affected by selection bias.  
Cohort follow-up rates affect external validity. A strong point in the MoBa study 
was that the participating women remained in the study. The follow up rate 
when included in the study was high; of women filling in Questionnaire 1, 93 
%, 92 % and 87 % filled in Questionnaire 2, Questionnaire 3 and 
Questionnaire 4, respectively [Magnus 2006].  
Exclusion and inclusion of participants in our study should lead us to be 
conscious about generalisation. We have included only mothers with one 
foetus. In Paper II and Paper III we only included women who were 
nulliparous and continent before pregnancy. It is therefore difficult to 
generalise the results to all obstetric wards or general practices. Isolated, we 
can for instance not say that weight loss postpartum is efficient for avoiding UI 
for any other population but primiparous women who were continent before 
pregnancy. In particular, Paper III is a hypothesis - generating paper trying to 
identify new associations and to test so called “established truths” (high BMI 
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leads to UI). It will be up to future studies to identify whether or not these 
findings are valid for other populations. 
Different distribution of demographic variables such as age, BMI, ethnicity, 
parity, mode of delivery etc in different populations outside Norway will 
decrease the external validity of our results in these settings. Our results are 
adjuseted and stratified for age, BMI and mode of delivery were appropriate. 
Our results will therefore have hight external validity in regions with different 
distribution of these variables. Still, our results will have lower external validity 
in regions were demographic variables (apart from age, BMI, mode of delivery) 
are distributed differently. As described under “Discussion of results” there are, 
however, striking similarities with effect estimates from both Australian and 
American UI studies [Brown 2010, Burgio 1996].  
Based on studies on MoBa data [Magnus 2006, Nilsen 2009] we conclude that 
the prevalence estimates, but not the effect estimates, might be affected by a 
socioeconomic selection bias. Our findings in Paper I appear to have high 
external validity in Scandinavia, America and Australia. Paper II and Paper III
are hypotheses – testing and based on a study population consisting of 
nulliparous women who were continent before pregnancy. Cautions should be 
taken in generalising these results to other groups of pregnant women.  
Inclusion criteria 
Paper I included only women with singletons who took part in the MoBa study 
once. Paper II and Paper III are based upon the same study population, but 
restricted to nulliparous women who were continent before pregnancy. To be 
able to explore incident UI in pregnancy or postpartum, women had to be 
continent before pregnancy. To explore associations between UI and 
pregnancy and labor, previous exposure to pregnancy and labor could elude 
associations. Nulliparous women who were continent before pregnancy 
represents the best clinical model of a pelvis unexposed to known pregnancy-
related risk factors, and thereby the best population to assess the risk of UI 
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associated with pregnancy and delivery. Farrell recommended this study 
population for exploring associations between UI and pregnancy and delivery 
[Farrell 2001]. Before Paper II was published in 2009, not many studies had 
used these inclusion criteria [Eftekhar 2006, Thomason 2007]. An increasing 
number of studies on UI the latter years have started using these inclusion 
criteria [Arrue 2010, Solans-Domenech 2010].  
Exposure data 
Due to our large study population, we were able to categorize/stratify the 
exposure variables to a larger extent than usually found in comparable 
literature, and we have still power to calculate risk estimates with high degree 
of precision.   
Most papers operate with two modes of delivery: CS and vaginal delivery 
[Turner 2009]. In Paper II, mode of delivery was categorized into elective CS, 
acute CS intended as elective CS, acute CS intended as SVD, SVD, vacuum 
and forceps delivery. No prior study has earlier presented mode of delivery – 
data like this. An unresolved research question has been whether or not there 
are different risks associated with the different CS groups. CS before or after 
the onset of labour are likely to affect the risk of UI differently. Women who are 
intended for elective CS are likely to be different from women intended for 
SVD [Chigbu 2007], independent of final mode of delivery. To understand the 
true effect of CS on UI, this type of potential confound by indication must be 
dealt with. In our study this confounding was reduced as we stratified mode of 
delivery in line with recommendation for future research on the association 
between CS and UI [Nygaard 2006]  
In Paper III data was stratified for BMI groups. Both BMI and weight gain are 
risk factors for UI [Townsend 2007]. Initial weight when becoming pregnant is 
likely to affect how the women respond to weight change in pregnancy. In 
addition, there are different weight gain recommendations for the different BMI 
groups [Rasmussen 2009]. Previous studies on UI and weight change in 
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pregnancy have not stratified for BMI. Due to the large study population we 
were able to achieve narrow CIs even after stratifying for pre pregnancy BMI. 
In Paper III, we used percentiles to categorize weight gain. We investigated 
how weight gain beyond the median affected UI; but to isolate the effects of 
extreme weight gain, we also analysed weight gain beyond the 90th percentile. 
Weight gain according to the Institute of Medicine’s recommendations for 
weight gain in pregnancy [Rasmussen 2009] could have been used, but our 
main focus was not to investigating how the Institute of Medicine’s 
recommendations affected UI. A recent study indicated that only 22 % of 
pregnant women gained weight according to the Institute of Medicine’s 
recommendations [Gould Rothberg]. Percentage of weight change, BMI 
change, weight gain according to the US Institute of Medicine 
recommendations, and absolute weight change were explored. These 
methods led to the same patterns of results. We presented both absolute 
weight change in kilograms at the 50th and 90th percentiles and weight 
change as a continuous variable; as we found these methods appropriate for 
our study aim and easy to interpret. If an association between UI and weight 
gain existed, analyses on the 90th percentile would be likely to reveal the 
association.  
Confounding 
A confounding variable is an extraneous variable that correlates with both the 
dependent and the independent variable, and can thereby lead to wrong 
conclusions. To avoid a false positive (Type I) error researchers must control 
for confounders [Altman 2006].  
The MoBa study aim at estimating associations between potential causal 
factors and ill health in mother and child. Exsposure data were obtrained 
through comprehensive data collection on factors such as diet, infections, 
hereditary factors, environmental toxins, medication, exposure to occupational 
hazards, lifestyle and previous disease, to mention some. This made it 
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possible to adjust for several important confounders. The linking of data to the 
MBRN registry made it possible to analyse objectively measured data 
registered during labour reported by health professionals. We performed 
analyses of confounding on birth variables like rupture degree 3-4, duration of 
labour, baby’s weight, head circumference etc. In addition we did confounder 
analyses on established risk factors such as age, BMI, mode of delivery etc. 
Confounding was evaluated by a variable’s effect on exposure and outcome 
and effect estimate. Possibilities for searching for potential confounding are 
almost infinite in the MoBa study. We focused mainly on available delivery and 
child variables as potential confounders. According to Dolan et al, few cohort 
studies on UI in pregnancy on primiparous women after delivery have used 
multivariate or logistic regression analysis to adjust for confounding variables 
[Dolan 2004]. However, variables found to be confounders in Paper I – III are 
in line with studies on UI in pregnancy who give an account for their use of 
confounder analyses [Dolan 2004, Farrell 2001, Glazener 2006]. The 
assessment of confounders was comprehensive and lead to improved 
accuracy of our effect estimates. 
Still, some limitations regarding confounders must be addressed; pelvic floor 
muscle training was not investigated as a confounder, as these data were to 
be explored by a different research group. We did not have access to delivery 
variables concerning CS as phase, stage, fetal distress, trial of instrumental 
delivery ahead of CS. As mentioned under Chapter 1.8.2, there are numerous 
potential confounders that can be investigated.  
We do not know all factors that are involved in the mechanism of UI. We can 
never rule out the possibility of rest confounding. However, when performing 
confounder analyses, only “established risk factors” (i.e. age, BMI, continence 
status in pregnancy and mode of delivery) appeared to affect exposure, 
outcome and effect estimate. The likelihood of any other confounder to 
substantially affect our UI estimates considerably appears to be small.  
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Internal validity 
Internal validity refers to the extent to which we can accurately state that the 
independent variable produced the observed effect. According to Rothman’s 
well recognised textbook “Modern epidemiology”, major threats to internal 
validity are confounding, selection bias and information bias.  
Information bias occurs due to mismeasurement of the variables studied. To 
find associations between exposure and outcome, exposure data must be 
valid. The MBRN data was quality tested and considered to have high 
accuracy. All filled-in questionnaires in MoBa were sent by mail to a central 
facility where they are registered, scanned and verified. Answers to specific 
questions were checked for logical content and consistency. Illegal values, 
values out of limit values and dependency rules are controlled. If the registered 
value in the databank was consistent with what the mother had written, the 
value was kept in the database even if it was absurd. Every scientist who 
works with the database must consider their limit values and define outliers.  
In Paper III we have excluded data on weight, weight gain and height that 
were very likely to be inaccurate (Figure 5).  
We did a descriptive statistic frequency test of height. We set the lowest cut-off 
for height at 1.40 m (this could be an average 13 year old at the 50 percentile 
weight curve and the 2.5 percentile height curve). We included the tallest 
women, reported to be 1.96 m.  
We did a descriptive statistic frequency test of weight (Figure 5). We set a 
general cutoff at 40 kg. There were 6 women reporting pre pregnancy weight 
between 0-10 kg, 2 women reporting weight 11-30 kg, and 3 women reporting 
weight 31-40 kg. The heaviest women reported pre pregnancy weight of 160 
kg. She was included.  
Several weight changes were excluded in analyses in Paper III (Figure 5). 
Women who reported weight loss during any time period in pregnancy were 
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excluded as well as women reporting impossible weight gain during a certain 
time period (i.e. reporting 60 kg before pregnancy and 670 kg in week 15 of 
pregnancy).  
Analyses must be performed carefully to achieve internal validity. The UI 
research group has long experience with register data, SPSS and regression 
analyses. Co-authors have been involved in the analyses. We have performed 
confounder analyses and adjusted were appropriate to give a more accurate 
effect estimate of the association between exposure and outcome. We believe 
that the chosen measures adequately assess what the study intended to 
investigate. 
We do not believe that information bias represent any threat to the internal 
validity in our study. Selection bias and confounding is discussed separately, 
and we concluded that they are likely not to represent a large threat to internal 
validity.  
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Figure 5. Included and excluded participants in study III 
Publication bias 
Articles with significant postive findings are more likely to be published than 
articles without such findings. In Paper II we did not find any significant 
differences in risk after SVD between women who were continent and 
incontinent in pregnancy, and we could thereby not point out a certain group 
who would benefit from CS based on continence status in pregnancy. In Paper 
III we could not identify weight gain in pregnancy as a major risk factor for 
neither UI in pregnancy nor postpartum. Despite so called “negative results” 
both papers were published in well recognized journals. Publication of 
negative results strengthens the evidence of these true null hypotheses.  
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Questionnaires 
The questionnaires consisted of 14 – 16 pages with questions. Questions 
regarding UI totalled only a minor part of the questionnaire. It is unlikely that 
there was a selection bias due to UI in the MoBa data material.  
UI was identified through questionnaire, not objective testing. Objective testing 
might reveal a different prevalence and incidence rate. Objective testing for UI 
is not recommended in epidemiologic research on UI. It would have been 
impossible to objectively test 100,000 pregnant women in week 15 and 30 for 
UI. The UI questions in MoBa are in accordance with the present definition of 
UI symptoms; “any complaint of involuntarily leakage of urine” [Haylen 2010].  
The research group on UI in Bergen has earlier used the Sandvik’s severity 
index questions [Sandvik 2006]. These validated questions concern frequency 
and amount. The questions on frequency focus on monthly leakage, weekly 
leakage and daily leakage. The MoBa UI questions are not formulated exactly 
the same way as Sandvik’s severity index, but concerns the same categories 
of UI. Sandvik’s severity index question number 2, 3 and 4 on frequency have 
the same meaning as the UI question 1, 2 and 3 on frequency in MoBa. When 
it comes to amounts, Sandvik’s severity index operates with “Drops or little” or 
“More”. We use the scale “Droplets”, “Larger amounts”, which corresponds to 
these two groups. Many surveys have used the same frequency and/or 
amount wording in questionnaires, among others Eason [Eason 2004]. An 
additional problem regarding the frequency and amount questions is that each 
type of UI was followed by a question regarding frequency and amount 
(Appendix 6). A woman with stress and urge UI will end up with 3 different 
severity scores. It is thereby impossible to estimate a mean frequency and 
amount – score for any UI. The MoBa questions on UI are not optimal, and are 
not validated, but we think that the content of our amount and frequency brings 
up the same information as other validated questionnaires on this subject. We 
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do, however, not have any proof of this. As a result, frequency and amount 
data are used with cautions.  
The timing of the questionnaires represents a weakness that has to be 
addressed. As women answered Questionnaire 3 in week 30 of pregnancy, we 
do not know the actual prevalence of UI just before delivery. The correct 
prevaelence of UI in pregnancy (at delivery) were thereby likely to be 
somewhat higher. We were also not able to investigate the association 
between weight gain during week 30 – delivery on UI in pregnancy. Practically, 
it would be very difficult to make all women answer a questionnaire just before 
or after giving birth.  
Questionnaire 1 had only one question regarding UI (Appendix 5). This 
question did not give information on type or severity of UI. Questionnaire 3 
(Appendix 6) answered in week 30 of pregnancy was therefore used to 
estimate UI before and during pregnancy. This might lead to incorrect data 
regarding UI before pregnancy. In Questionnaire 3 30,631 women reported 
being continent before pregnancy. Of these, only 65 women (0.2 %) reported 
having UI before pregnancy in Questionnaire 1. Data from Questionnaire 3 
thus appears to correspond well with data from Questionnaire 1.  
4.1.2 Methodological weaknesses 
Recall bias 
Even though MoBa is a prospective cohort study, the possibilities of recall bias 
ought to be addressed. The women were asked to recall UI and weight before 
the first pregnancy. Questionnaire 1, answered in week 15, asked “Did you 
have UI before pregnancy?”. Unfortunately, the questionnaire lacked 
information regarding stress UI, urge UI, mixed UI, frequency and amount. In 
Questionnaire 3 answered in week 30, the women were also asked about UI 
before pregnancy. These questions also gave information about type and 
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severity of UI. These data were used to calculate prevalence of UI before 
pregnancy. Viktrup found that women remember the onset of UI in association 
with pregnancy incorrectly 5 years after delivery [Viktrup 2001]. Pregnancy is a 
very special phase in a woman’s life. Pregnant women are particular aware 
their own body, body changes and onset of symptoms in pregnancy. We 
believe that women in week 30 of pregnancy are capable of remembering 
whether or not they had UI before pregnancy, but we can not rule out 
underestimation of UI prevalence before pregnancy. 
Weight before pregnancy and weight at delivery were reported retrospectively. 
However, one study indicated high correlation between recall of prepregnancy 
weight and actual prepregnancy weight, even many years after delivery 
[Tomeo 1999]. In addition, 6 months postpartum, there is high correlation 
between self-reported weight and documented weight in pregnancy [Oliveira 
2004]. All Norwegian women have a pregnancy chart documenting weight 
before pregnancy and at the time of birth. Hence, data for weight at these 2 
time points were easy for women to recollect. 
Statistical analyses 
As time passes by, research methods and statistical analyses develops and 
matures. In Paper I OR was used as risk estimate, as this was the effect 
estimate used in comparable articles. Prevalent conditions and large ORs will 
lead to a gap between OR and RR; the OR estimate will be higher than the RR 
estimate. It is common to interpret OR as RR, and therefore falsely interpret 
the risk as too high. RR is therefore the recommended risk parameter in 
studies with high prevalence in the unexposed group. RR is also the 
recommended risk parameter in cohort studies.  
In Paper II we therefore presented both OR and RR. All OR and CI were 
converted to RRs and corresponding CI by use of the formula RR = OR/((1 – 
P) + (OR · P)) [Zhang 1998]. In this formula, P is the prevalence of UI in the 
unexposed group.  
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In Paper III we further refined the methodology by log binomial regression 
analyses in STATA to estimate RR. Only RR was presented. There were large 
differences between OR and RR, but only tiny differences in RR estimates 
between the two ways of estimating RR. The three papers thereby have 
different ways of calculating effect estimates. Recent years there are published 
several articles on UI in pregnancy using RR as their effect measurement 
[Baydock 2009, Hantoushzadeh 2010]. It is a weakness that Paper I, II and III
do not have similar risk analyses. We recommend presenting RR in future 
studies on groups with high prevalence of UI. Still, several recent studies with 
high prevalence of UI present high OR as risk parameters [Brown 2010, Diez-
Itza 2010]. Some recent articles have however used hazard ratio (HR) 
[Solans-Domenech 2010].  
In Paper III, we analysed weight change among all women, underweight 
women, normal weight women and overweight women. The association 
between weight change according to the 50th and 90th percentile and UI in 
week 30 was analysed for two different time periods. The association with UI 6 
months postpartum was analysed for six different time periods. Analyses on 
weight loss from delivery – 6 months postpartum was in addition stratified for 
continence status in pregnancy during. A total of 44 regression analyses with 
95 % CI was performed, statistical significant associations were stated when p 
< 0.05. Due to the number of analyses, we were likely to find at least two false 
significant findings. Retrospectively, we could have used Bonferroni method to 
avoid type I errors. Few articles about UI use Bonferroni; I was only able to 
identify 8 articles on UI, all with focus on urodynamics, which had performed 
Bonferroni analyses. Bonferroni is performed by considering the number k of 
null hypothesis (n=44) that are to be tested and the overall type 1 error rate p 
(p < 0.05) by ordering the p-values and comparing the smallest p-value to /k. 
If that p-value is less than /k, the hypothesis is rejected and analyses are 
done all over with the same  and test the remaining k − 1 hypothesis and 
compare the smallest one to / (k − 1). This is done until the hypothesis with 
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the smallest p-value cannot be rejected. At that point all hypotheses that have 
not been rejected at previous steps are accepted.  
Due to our large sample size, the majority of our p-values were < 0.01. 
However, many effect estimates in Paper III was small and several CI were 
close to zero, leading to p-values 0.05 < x < 0.01. It is thereby a chance of 
type I error. On the other hand, we found a trend in significant findings; were 
significant associations were identified in Paper III; both the 50th and 90th 
percentile analyses within a BMI group were generally significant. In addition, 
significant findings were generally in association within the same time period; 
that is week 0 – 15 and UI in pregnancy, and week 0 – 6 months postpartum, 
delivery – 6 months postpartum and UI postpartum. This increases the 
likelihood of our findings to not be exposed to type I errors in this respect.  
Power 
A study will try to achieve the highest possible power, so that if the null 
hypothesis is false, the CI will be narrow and p – value will tend to be small 
numbers [Rothman 1998]. Power was not calculated, as we had a given data 
set to work on. Our dataset was based on enrolled women in 2006. There was 
no reason to believe that we would lack power in our analyses. However, in 
stratified analysed; for instance on underweight women gaining weight > 90th 
percentile (n = 26 – 31), or on women who were continent in pregnancy and 
delivering by acute CS intended as elective CS (n = 4) an even larger study 
population might have helped us avoid a type II mistake (not finding significant 
associations and thereby not rejecting the null hypothesis).  
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4.2 Discussion of results 
4.2.1 Paper I 
In Paper I we investigated prevalence, incidence and risk factors for UI in 
pregnancy among all women in MoBa at the time.  
Incidence and prevalence 
Prevalence of UI before pregnancy was 26 %. A large cohort study from 
Australia has reported similar prevalence of UI among a general population of 
women aged 18 to 50 years, with 24 % [Chiarelli 1999b]. Mean age in our 
study population was 29.5 years. Prevalence of UI among women 30 – 34 
years in the Norwegian Epincont study was 18 % [Hannestad 2000]. A wide 
range of prevalence figures has been presented among both nulliparous (5 – 
39%) and parous (19 – 48%) women [Foldspang 1992, Hvidman 2002, 
Rortveit 2001].  
Epidemiologic data are scarce on cumulative incidence of UI in pregnancy. 
Incidences of UI in pregnancy are in the range of 8 – 57 % (Table 1). We 
reported a cumulative incidence of 45% of any UI. A recent study on 
nulliparous women found a cumulative incidence rate of UI in pregnancy of 39 
% [Solans-Domenech 2010].  
In Paper I prevalence of UI in pregnancy was 56 % (48 % among nulliparous, 
67 % among parous women). Prevalence of UI in pregnancy varies widely in 
previous studies, with figures ranging from 4 – 70 % among nulliparous 
women, and from 14 – 85 % among parous women [Francis 1960, Groutz 
1999, Hojberg 1999, Hvidman 2002, Morkved 1999, van Brummen 2006b] 
(Table 2). Our prevalence estimate of 58 % of UI pregnancy distributed 
unevenly on three types of UI was based on real time report of symptoms in a 
large, unselected population, similar to figures reported in other prospective 
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studies of pregnant women [Burgio 1996, Chiarelli 1997, Raza-Khan 2006]. A 
recent study on UI in pregnancy is also in line with our findings: an Australian 
study found a prevalence of UI among nulliparous women in third trimester of 
56 % [Brown 2010].  
The increased prevalence of UI in pregnancy was mostly due to high incidence 
of stress UI and mixed UI. This is in line with findings in previous studies that 
have investigated impact of pregnancy on type of UI [Dolan 2004, van 
Brummen 2006b, Viktrup 1992]. Several studies on UI in pregnancy have 
reported data on stress UI only, with estimates between 9 – 85 % [Eason 
2004, Francis 1960, Groutz 1999, Scarpa 2006, Viktrup 1992]. Our estimate of 
32 % stress UI is in the middle of the published range.  
Risk factors 
Age, parity and BMI are three main risk factors for UI in younger women 
[Burgio 1996, Chiarelli 1999b, Foldspang 1992, Groutz 1999, Hannestad 2003, 
Hojberg 1999, Hvidman 2002, Rortveit 2001]. In Paper I, adjusted analyses 
showed that parity was the strongest risk factor for UI both before and during 
pregnancy, with OR  2 for parous women. This is in line with other studies 
[Chiarelli 1997, Foldspang 1999, Scarpa 2006]. Some authors have found a 
certain threshold for the number of deliveries as risk factor for UI [Faúndes 
2001, Rortveit 2001]. Our findings support that the first delivery has the 
strongest impact on UI before a new pregnancy, but subsequent deliveries 
also add to the risk for UI. However, the association with parity was weaker 
among pregnant women, indicating that pregnancy itself becomes a more 
important risk factor for UI when pregnant.  
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4.2.2 Paper II 
In Paper II we investigated incidence and prevalence of UI 6 months 
postpartum, and how UI in pregnancy and mode of delivery affected UI 
postpartum among primiparous women who were continent before pregnancy.  
Incidence and prevalence 
In cohort studies incidence of UI postpartum among primiparous women who 
were continent both before and in pregnancy varies from 0 – 26 % [Farrell 
2001, Glazener 2006, Huebner 2010, Solans-Domenech 2010, Viktrup 1992]. 
The cumulative incidence of UI 6 months postpartum was 21%. Reasons for 
the high incidence may be lower CS rates and higher rates of instrumental 
vaginal delivery in our study compared to the other studies [Farrell 2001, 
Glazener 2006, Viktrup 1992]. Also, the threshold to label UI was low, as UI 
last month was used to define UI. Our cumulative incidence on UI after CS, 
SVD and instrumental delivery were, however, equal to other studies [Farrell 
2001].  
UI was reported by 31% (3,991/12,679) women 6 months after delivery. In a 
recent systematic review of UI during the first 3 months postpartum, the pooled 
prevalence of any postpartum UI was 29% (95% CI 27-30%) among 
primiparous women 3 months postpartum [Thom 2010]. Due to low response 
rate in MoBa, Paper II was not found eligible for this review. Our findings are, 
however, in line with the results of this review.  
Mode of delivery 
We found that 3,710 of 10,714 (35%) women had UI after vaginal delivery. 
Reported prevalence of UI among primiparous women after vaginal delivery 
varies between 20 – 31 % [Eason 2004, Schytt 2004]. Recent cohort studies 
[Borello-France 2006, Eftekhar 2006], as well as reviews [Turner 2009] found 
similar prevalence range. Reasons for our somewhat higher prevalence 
estimate might be the use of prospective study design and lower CS rates. 
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There is growing body of evidence documenting vaginal delivery as predictor 
of UI also later in life [Burgio 2003, Glazener 2006, Rortveit 2003a].   
According to general criteria used to claim that a risk factor is established, 
vaginal delivery fulfills these criteria; there is a large significant risk increase of 
UI after SVD, indicating a clinically important association. SVD is a risk factor 
in different studies [Farrell 2001, Hannah 2004], in different study populations 
[2001, Kozak 2002] and in different study designs [Groutz 2004, Hvidman 
2003]. There is to a large degree consistency in the literature; the risk factor is 
reproduced in different studies. But also in studies on UI and SVD, some 
results are unambiguous [Thomason 2007]. There is a dose response 
dependent relationship between UI and SVD [McKinnie 2005] (but results are 
diverging even in Nordic studies [Altman 2006]). There appears to be a causal 
relationship between SVD and UI, as SVD is biologically plausible to affect the 
pelvic floor. Our article adds to the existing documentation on SVD as a risk 
factor for UI postpartum.  
There is an ongoing controversy about the effect of assisted vaginal delivery 
on UI [Schytt 2004] as results do not show a clear tendency towards increased 
prevalence of UI postpartum [Farrell 2001, Hvidman 2003, Rortveit 2003b]. A 
recent study on primiparous women found increased risk of UI after assisted 
vaginal delivery [Jundt 2010]. Unfortunately, MBRN has no further information 
on which instrumental delivery failed and resulted in non-elective CS, or at 
what stage of delivery non-elective CS was carried out. This kind of missing 
information is a limitation of this study. 
A referee for Paper II claimed there existed no documentation on UI after non-
elective CS intended as elective CS or non-elective CS intended as SVD. We 
have not been able do come across articles, neither before nor after our 
publication, that presents such data. To update clinicians we presented 
detailed data for non-elective CS by splitting this group in three (those who 
were intended to deliver vaginally, those who were intended to deliver by 
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elective CS and an unspecified group). There were, however, no significant 
differences between these groups. A recent study on primiparous women have 
looked into how CS among women who were a) not in labour, b) in labour but 
not pushing or c) in labour and pushing affected UI postpartum [Boyles 2009]. 
In line with our results, they found no significant differences between the 
groups.  
Continence status in pregnancy 
We found an OR of 3.5 for UI 6 months postpartum among women who had UI 
in pregnancy compared with those who were continent during pregnancy. 
When reanalysing available data in previously published articles for 
comparison, ORs for UI postpartum among primiparous women by continence 
status in pregnancy vary from 2.5 to 9.2 [Foldspang 2004, Fritel 2004, 
Glazener 2006, Groutz 2004, Schytt 2004, van Brummen 2007, Viktrup 1992, 
Wilson 1996]. We identified six studies investigating the relationship between 
continence status in pregnancy and continence status postpartum in 
previously continent primiparous women, showing ORs of 1.7 [Glazener 2006], 
1.9 [Viktrup 1992], 2.0 [Wilson 1996], 3.7 [Arrue 2010] and 5.8[Diez-Itza 2010], 
and 7.8 [Groutz 2004] (Table 6). There was no possibility for adjustments of 
OR in our reanalyses. Several new articles show that UI in pregnancy is an 
important predictor for UI both postpartum [Arrue 2010, Diez-Itza 2010, Wang 
2010] and later in life [Altman 2006, Burgio 2003, Fritel 2004, Hvidman 2003, 
Schytt 2004, van Brummen 2006a, van Brummen 2007, Viktrup 2006].  
Mode of delivery and continence status’ association with UI postpartum 
In Breslow-Day analyses we found no significant difference in risk for UI 
postpartum after CS compared to SVD among women who were continent or 
incontinent in pregnancy. Glazener et al [Glazener 2006] was the only 
research group identified investigating nulliparous women who were continent 
before pregnancy, stratified for continence status in pregnancy and then 
analysed delivery parameters with the same approach as we used. For 
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comparison, we set CS as reference group in Glazener’s study and any CS as 
reference group in our material. Reanalysed this way, the OR for UI after 
vaginal delivery among women who were continent in pregnancy was 3.6 in 
Glazener’s study and 3.3 in Paper II. Among women who were incontinent in 
pregnancy, the ORs were 2.6 and 2.6, respectively. Although Glazener et al 
used a retrospective design with data collection 3 months postpartum, our 
findings correspond very well with their results.  
Although there was no statistically significant difference in RR reduction 
between groups, there was still a large difference in absolute risk reduction (-
15% vs. -31%) (Table 8). However, RR is a better and more correct measure 
of risk in this study. It is an adjusted estimate, taking confounding into account. 
In addition, Breslow-Day test can be applied when comparing RR to see if the 
risk estimates are significantly different.  
Table 8. Number (N), percentage and adjusted OR and RR for urinary 
incontinence 6 months postpartum by delivery mode, stratified for continence 
status in pregnancy.  
 Continent in pregnancy Incontinent in pregnancy 
 N % OR  RR CI N % OR RR CI 
Elective CS 18 8 1  1 Ref 25 20 1 1 Ref 
Acute CS intended as elective CS 4 13 1.6  1.4 0.4-4.1 3 21 1.4 1.3 0.3-2.9
Acute CS intended as SVD 66 8 1.0  1.0 0.6-1.7 153 30 1.9 1.6 1.1-2.2
Unspecified CS 3 8 0.7  0.7 0.2-2.8 8 29 2.0 1.7 0.7-2.8
SVD 1,166 23 3.9  3.2 2.1-4.7 1,837 51 5.5 2.9 2.3-3.4
Vacuum 250 26 3.9  3.2 2.1-4.6 337 56 6.4 3.1 2.4-3.6
Forceps 55 30 5.5  4.0 2.6-5.8 58 50 4.9 2.8 2.0-3.4
CS = cesarean section, SVD = spontaneous vaginal delivery, OR = odds ratio, RR = relative 
risk, CI = confidence intervals.  
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4.2.3 Paper III 
In Paper III we investigated how weight gain and weight loss in association 
with pregnancy was associated with UI 6 months postpartum among 
primiparous women who were continent before pregnancy. The subject was 
surprisingly timely in the light of an increasing number of reviews the last two 
years concerning weight and UI.  
Weight gain and UI in pregnancy 
Weight gain between week 0 – 15 of pregnancy was associated with UI in 
week 30 of pregnancy, while weight gain between week 15 – 30 showed no 
such association. Other studies have also found no statistically significant 
association between total weight gain in pregnancy and UI before delivery 
[Eason 2004, Kristiansson 2001, Sottner 2006] (Table 7). A recent Spanish 
study on 478 primiparous women confirms these findings [Diez-Itza 2009]. No 
studies have investigated the effect of weight gain during different trimesters 
on UI, and only two articles on weight and UI in pregnancy present adjusted 
analyses [Diez-Itza 2009, Eason 2004].   
Weight gain and UI postpartum 
Weight gain in pregnancy did not affect UI 6 months postpartum. This made 
the association between weight gain during week 0 – 15 and UI in pregnancy 
less likely to be clinically important. This is in accordance with other studies. 
Eason et al [Eason 2004] found no increased risk for UI 3 months postpartum 
among women who gained > 17 kg in pregnancy compared to women who 
gained < 11 kg. A study from 2010 [Diez-Itza 2010] found no association 
between total weight gain in pregnancy and persistent UI 1 year postpartum. 
Our results were contrary to an Italian study [D'Alfonso 2006]. We reanalysed 
their data and found an unadjusted RR of 2.0 for UI 3 weeks postpartum 
among women who gained  15 kg in pregnancy. These articles did not stratify 
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for pre pregnancy BMI nor clarified their use of weight groups [D'Alfonso 2006, 
Eason 2004, Kristiansson 2001, Sottner 2006]. Our findings were also in 
contrast to results for weight gain in a cohort of non-pregnant women in The 
Nurses Health Study [Townsend 2007];  reporting an OR of 3.5 for frequent UI 
in a general population of women who gained more than 20 kg over a four 
year time period.  
There were significant associations between high weight gain from before 
pregnancy through 6 months postpartum and having UI at 6 months 
postpartum. This weight gain represents mainly adiposity and not fetus, uterus 
etc.  Recent years there have been published several reviews concerning 
weight and UI [Bart 2008, Greer 2008, Hunskaar 2008, Khong 2008, Subak 
2009]. There is strong evidence, both in cross sectional studies and cohort 
studies, that increasing BMI is a risk factor for UI in general. These reviews do 
not concern weight gain during or after pregnancy, but our study in general 
adds to the existing literature concluding that increased adiposity is associated 
with UI. It has to be added that the findings of only minor association between 
weight gain in pregnancy and UI are not in line with the existing literature on 
high BMI and UI (See chapter 1.8.2).  
Weight loss and UI postpartum  
There was a decreased risk of UI 6 months postpartum by weight loss from the 
time of delivery – 6 months postpartum, both among women who were 
continent and incontinent in pregnancy (Table 9). One study of non-pregnant 
women have found similar association with weight loss as our study; an RCT 
study reported that 7% of overweight women with frequent UI became urinary 
continent after a mean weight loss of 7.8 kg over a 6 month period [Subak 
2002]. Several reviews have been published the recent years regarding weight 
loss and UI [Altman 2009, Hunskaar 2008, Khong 2008, Natarajan 2009]. We 
have not, however, identified any study looking into the effect of weight loss 
postpartum on UI.  
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Table 9. RR of UI 6 months postpartum among primiparous women in 
Norway who were incontinent or continent in pregnancy, by weight loss 
from delivery – 6 months postpartum. Data are given for the total study 
group, and weight gain is categorized by 50 and 90 percentiles. 
Incontinent in pregnancy Continent in pregnancy 
Percentile Weight 
loss (kg) 
N Prevalence 
UI  (%) 
Adjusted 
RR 
95% CI N Incidence 
UI  (%) 
Adjusted 
RR 
95% CI 
1 – 50 0 – 14.0 2,520 1,283  (51) Ref  3,549 815  (23) Ref  
51 – 90 14.1 – 21.0 1,807 825  (46) 0.9 0.8, 0.9* 2,882 549  (19) 0.8 0.7, 0.9* 
> 90  21.1 419 157  (38) 0.7 0.6, 0.8* 643 118  (18) 0.7 0.5, 0.8* 
Obstetricians have several potential efficient methods to reduce UI after 
delivery; minimising forceps deliveries and episiotomies, by allowing 
passive descent in the second stage, and by selectively recommending 
elective CS [Handa 1996]. However, pregnant women are most often 
recommended pelvic floor muscle training to prevent UI. Women 
suffering from UI in association with pregnancy are in general not 
informed about any other ways to achieve continence.  
A recent study based on primiparous women in the MoBa study found 
that 57 % of the participants did pelvic floor muscle training  1 pr week 
in week 30 of pregnancy  [Bo 2009]. A recent RCT found a RR of 0.8 
for UI 3 months postpartum after pelvic floor muscle training compared 
to no training [Mason 2010]. A Cochrane review on pelvic floor muscle 
training in association with pregnancy found that pregnant women 
without prior UI who were randomised to intensive pelvic floor muscle 
training in pregnancy were less likely than women randomised to no 
pelvic floor muscle training to report UI 6 months postpartum (RR 0.7) 
[Hay-Smith 2008]. Women with persistent UI 3 months postpartum who 
received pelvic floor muscle training, 30 % less women reported UI 12 
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months postpartum compared to women who did not receive treatment 
(RR 0.79) [Hay-Smith 2008]. In Paper III we found a risk reduction (RR 
0.7) for UI 6 months postpartum after weight loss > 90th percentile from 
delivery to 6 months postpartum both among women who were 
continent and incontinent in pregnancy. In other words, the effect of 
weight loss found in our study is in line with the effect of pelvic floor 
muscle training. It should be commented that a large weight loss 
postpartum could imply substantially more effort than pelvic floor 
muscle training. We believe that the associations between UI and 
weight loss postpartum in our study are of clinical importance. Weight 
loss should therefore be considered as a possible addition to pelvic 
floor muscle training. Weight loss postpartum, together with pelvic floor 
muscle training [Hay-Smith 2008, Morkved 1997, Morkved 2000], may 
decrease the prevalence of women with UI postpartum. 
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5. Conclusion 
5.1 Paper I 
The prevalence of UI increases substantially in pregnancy; the prevalence 
increased from 26% before pregnancy to 58% in week 30. The cumulative 
incidence was 46%.  Incontinence both before and in pregnancy seems to be 
associated with parity, age, and body mass index.  
5.2 Paper II 
UI was reported by 31% of the women 6 months after delivery. The cumulative 
incidence was 21 %. Women who were continent in pregnancy had statistically 
significant lower prevalence of UI postpartum compared with women who were 
incontinent. Elective CS was associated with less risk of UI postpartum 
compared to SVD. There were, however, no statistically significant differences 
in risks between women who were continent and incontinent in pregnancy 
depending on mode of delivery. Our findings indicate that the association 
between mode of delivery and continence status postpartum was not 
influenced by incontinence status in pregnancy. Prediction of a group with high 
risk of UI according to mode of delivery cannot be based on continence status 
in pregnancy. 
5.3 Paper III 
Weight gain in pregnancy was of little relevance to continence status in 
pregnancy and postpartum, and can therefore not explain the high prevalence 
of UI in pregnancy among nulliparous women. High weight gain from start of 
pregnancy through 6 months postpartum was the only weight-associated risk 
factor for UI 6 months postpartum. Weight loss postpartum seems to be 
important for regaining continence and avoiding UI 6 months postpartum, and 
should therefore be addressed during continence promotion. Our findings can 
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help urinary incontinent women with continence instructions beyond pelvic 
floor training by encouraging them to loose weight after delivery.  
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6. Implications 
Researchers ought to be careful not to exaggerate the clinical implications of 
their research results. The following implications of Paper I – III may be 
anticipated:  
6.1 Implications 
The results in Paper I may contribute to increased focus on UI during 
pregnancy as a highly prevalent condition. Paper II may be a contribution to 
the discussion of CS to prevent UI. I have the highest anticipations for Paper 
III. The results may lead to awareness of weight loss post partum as an 
important conservative way of continence promotion.   
6.2 References to own research 
It usually takes time for an article to reach recognition and to be cited. Few 
articles become frequently cited reference articles. By using ISI Web of 
Knowledge number of citations for each article can be found. In addition, 
referral to my papers has been identified when reading articles.  
All 3 papers are published in recognized journals of their kind. Paper I was 
published in “Obstetrics and Gynecology”; the international obstetric journal 
with the highest impact factor (4.4, 2009). Paper II was published in “British 
Journal of Obstetrics and Gynecology”; the second highest rated international 
obstetric journal with an impact factor (3.4, 2009). Paper III was published in 
“American Journal of Epidemiology”; the international epidemiology journal 
with the highest impact factor (5.6, 2009).  
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6.2.1  Citations Paper I 
Paper I was published in 2007. Recent years it has been cited in several 
articles as an important reference article on UI in pregnancy. By June 2011 
Paper I had been cited in 21 articles during the last 4 years [Adaji 2010, Al-
Mehaisen 2009, Arrue 2010, Brown 2010, Diez-Itza 2009, Fiadjoe 2010, 
Herbruck 2008, Kawaguchi JK 2010, Kim 2007, King 2010, Klemetti , Kocaoz 
2010, Lukasse 2009, Marecki 2010, Martins 2010, Mason 2010, Milsom 2009, 
Panayi 2009, Sharma 2009, Solans-Domenech 2010, Thom 2010]. Paper I
has also been self cited in Paper II and Paper III. 
Paper I has been frequently cited both in the introductions and discussion 
sections in articles regarding UI in pregnancy [Adaji 2010, Arrue 2010, Brown 
2010, Kim 2007, King 2010, Kocaoz 2010, Marecki 2010, Martins 2010, 
Mason 2010, Solans-Domenech 2010]. Several of these articles highlight 
results from Paper I in the text, and refer to Paper I as the largest comparable 
article [Milsom 2009]. Many of the above articles compare their findings to 
Paper I, and conclude that their results are in line with our results [Arrue 2010, 
Brown 2010, Martins 2010, Mason 2010]. Due to different inclusion criteria, 
one study concluded that their figures of UI in pregnancy was not line with our 
findings [Adaji 2010].  
Some articles refer to Paper I regarding BMI, age and parity as risk factors for 
UI [Adaji 2010, Arrue 2010, Brown 2010, Fiadjoe , Kim 2007, King 2010, 
Kocaoz 2010, Marecki 2010, Martins 2010, Mason 2010, Solans-Domenech 
2010]. They in general conclude that these risk factors must be considered 
“established”, and further research on these risk factors are probably not 
needed.  
Due to the size of the study population, the quality and the interest so far, 
hopefully Paper I will be a frequent cited article in UI research in pregnancy in 
the coming years.  
_____________________________________________________________________ 
99
6.2.2  Citations Paper II 
Paper II was published in 2009. By May 2011 the article had already been 
cited 11 times; [Arrue 2010, de Souza Santos 2010, Diez-Itza 2010, Fritel 
2010, Golding 2009, Humburg, Martins 2010, Menezes 2010, Okamoto 2010, 
Solans-Domenech 2010, Thom 2010].  
Paper II has been most cited in regards of UI prevalence postpartum [Martins 
2010, Solans-Domenech 2010, Thom 2010]. Figures in these recent articles 
are in general in line with our findings. However, our UI incidence estimates 
postpartum in one article differs from this article (21% vs. 9%) [Solans-
Domenech 2010], probably due to different CS rates in the study population. 
Several citations refer to Paper II regarding UI in pregnancy as a risk factor for 
UI postpartum [Arrue 2010, Diez-Itza 2010, Menezes 2010]. The latter to 
articles concluded that UI in pregnancy was the only independent risk factor 
for UI postpartum. Our RR increase for UI postpartum among women with UI 
in pregnancy compared to women without UI in pregnancy was in line with 
these recent articles.  
Paper II is a very large cohort study looking into the association between 
mode of delivery and UI postpartum. Therefore, several articles refer to Paper 
II in this regard [Diez-Itza 2010, Fritel 2010, Solans-Domenech 2010]. The 
latter article also refers to Paper II’s focus on the effect of instrumental 
delivery.  
Only one article has cited us regarding the conclusion; association between UI 
in pregnancy and mode of deliver on UI postpartum [Menezes 2010].  
6.2.3  Citations Paper III 
Paper III was published in 2010, six months before this text was written. Paper 
III has yet to be cited. However, the abstract publication of Paper III from ICS 
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2009 has been cited once [Cartwright 2009]. The author gives a brief summary 
of our article, and concludes “Post-partum weight loss should be encouraged 
on the basis of these data.” 
6.2 Future research 
During my time as researcher, I have been thinking of both possible and 
impossible research projects on UI. As RCT studies indeed reach Level 1 of 
evidence while cohorts reach Level 2; it could be interesting to do a the 
following hypothetical experiments:  
- Randomise women to SVD or CS to find the true association with UI 
postpartum. 
- Randomise women at delivery to “weight loss” or “no weight loss” to find 
the true association with UI postpartum. 
- Randomise women at fertilization to “weight gain” and “no weight gain” 
in pregnancy to separate pregnancy as a risk factor from weight gain as 
a risk factor.  
All three experiments would of course be hypothetical and impossible to 
perform and highly unethical. Level 2 of evidence will thereby maybe be the 
best possible evidence to these research questions.  
Our conclusion in Paper II and Paper III ought to be in line with future 
research, and consistency in the literature must exist before our results might 
one day will be part of so-called established risk factors. Research in different 
setting, different populations and including not only nulliparous women would 
add knowledge and external validity to future conclusions. 
There are still many unresolved research questions regarding weight, weight 
change and UI. As written in Chapter 1.8.2; there are many interesting factors 
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surrounding weight and UI that has yet to be investigated. There is need for 
prospective studies, preferably lifelong studies, investigating the duration of 
weight and weight gain’s association with incident UI. Validated questionnaires 
should be used. We need to know whether weight represents it muscles, 
pregnancy, oedema or body fat? The study should compare waist-hip-ratio, 
waist circumference, total body fat and visceral fat to find the best parameter 
to be associated with UI. The study should have data to control for other 
diseases, hormonal changes, social characteristics and distinguished food 
intake. Studies should try to determine how these factors influence UI, and 
how they affect the association between weight and UI. Analyses in future 
studies on weight and UI should differentiate between the types of UI. I believe 
future studies will bring on new interesting information to change the 
established truths on weight and UI.  
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